CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tetracarboxylic acid
Accession: CHEBI:35742
browse the term
Definition: An oxoacid containing four carboxy groups.
Synonyms: related_synonym: Formula=C4H4O8R; tetracarboxylic acids
G
Acaca
acetyl-CoA carboxylase alpha
increases expression multiple interactions
ISO
2-acetyltributylcitrate results in increased expression of ACACA mRNA; 2-acetyltributylcitrate results in increased expression of ACACA protein [2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ACACA mRNA
CTD
PMID:37055963
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acacb
acetyl-CoA carboxylase beta
increases expression
ISO
2-acetyltributylcitrate results in increased expression of ACACB mRNA
CTD
PMID:37055963
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Acot1
acyl-CoA thioesterase 1
increases expression
ISO
2-acetyltributylcitrate results in increased expression of ACOT1 mRNA
CTD
PMID:37055963
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acot2
acyl-CoA thioesterase 2
increases expression
ISO
2-acetyltributylcitrate results in increased expression of ACOT2 mRNA
CTD
PMID:37055963
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
G
Acot3
acyl-CoA thioesterase 3
increases expression
ISO
2-acetyltributylcitrate results in increased expression of ACOT3 mRNA
CTD
PMID:37055963
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
G
Acot4
acyl-CoA thioesterase 4
increases expression
ISO
2-acetyltributylcitrate results in increased expression of ACOT4 mRNA
CTD
PMID:37055963
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
increases expression
ISO
2-acetyltributylcitrate results in increased expression of ALDH3A2 mRNA
CTD
PMID:37055963
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Cd36
CD36 molecule
increases expression multiple interactions
ISO
2-acetyltributylcitrate results in increased expression of CD36 mRNA; 2-acetyltributylcitrate results in increased expression of CD36 protein [2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD36 mRNA
CTD
PMID:37055963
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
increases expression
ISO
2-acetyltributylcitrate results in increased expression of CYP11A1 mRNA
CTD
PMID:28235592
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
increases expression
ISO
2-acetyltributylcitrate results in increased expression of CYP11B2 mRNA
CTD
PMID:28235592
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression increases expression
ISO
2-acetyltributylcitrate results in decreased expression of CYP17A1 mRNA 2-acetyltributylcitrate results in increased expression of CYP17A1 mRNA
CTD
PMID:28235592 PMID:37055963
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of CYP1A2 mRNA
CTD
PMID:37055963
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c24
cytochrome P450, family 2, subfamily c, polypeptide 24
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of CYP2C55 mRNA
CTD
PMID:37055963
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases activity increases expression
ISO
2-acetyltributylcitrate promotes the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; 2-acetyltributylcitrate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Calcitriol promotes the reaction [2-acetyltributylcitrate results in increased activity of CYP3A4 protein]; Calcitriol promotes the reaction [2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA]
CTD
PMID:21742782
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
2-acetyltributylcitrate results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:21742782
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp51
cytochrome P450, family 51
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of CYP51 mRNA
CTD
PMID:37055963
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of CYP7B1 mRNA
CTD
PMID:37055963
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Dhcr7
7-dehydrocholesterol reductase
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of DHCR7 mRNA
CTD
PMID:37055963
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
increases expression
ISO
2-acetyltributylcitrate results in increased expression of EHHADH mRNA
CTD
PMID:37055963
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Elovl7
ELOVL fatty acid elongase 7
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of ELOVL7 mRNA
CTD
PMID:37055963
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
G
Fabp4
fatty acid binding protein 4
multiple interactions increases expression
ISO
[2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FABP4 mRNA 2-acetyltributylcitrate results in increased expression of FABP4 mRNA
CTD
PMID:37055963
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fasn
fatty acid synthase
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of FASN mRNA
CTD
PMID:37055963
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Gal3st1
galactose-3-O-sulfotransferase 1
increases expression
ISO
2-acetyltributylcitrate results in increased expression of GAL3ST1 mRNA
CTD
PMID:37055963
NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
2-acetyltributylcitrate results in increased expression of GPAT3 mRNA
CTD
PMID:37055963
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpcpd1
glycerophosphocholine phosphodiesterase 1
increases expression
ISO
2-acetyltributylcitrate results in increased expression of GPCPD1 mRNA
CTD
PMID:37055963
NCBI chr 3:119,787,681...119,832,550
Ensembl chr 3:119,787,682...119,832,517
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of HMGCS1 mRNA
CTD
PMID:37055963
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of HSD3B2 mRNA
CTD
PMID:37055963
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsd3b2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
increases expression
ISO
2-acetyltributylcitrate results in increased expression of HSD3B2 mRNA
CTD
PMID:28235592
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
G
Lipg
lipase G, endothelial type
increases expression
ISO
2-acetyltributylcitrate results in increased expression of LIPG mRNA
CTD
PMID:37055963
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lss
lanosterol synthase
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of LSS mRNA
CTD
PMID:37055963
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of MSMO1 mRNA
CTD
PMID:37055963
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Ncoa1
nuclear receptor coactivator 1
multiple interactions
ISO
2-acetyltributylcitrate promotes the reaction [NCOA1 protein binds to NR1I2 protein]
CTD
PMID:21742782
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions
ISO
2-acetyltributylcitrate promotes the reaction [NCOA2 protein binds to NR1I2 protein]
CTD
PMID:21742782
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity multiple interactions
ISO EXP
2-acetyltributylcitrate results in increased activity of NR1I2 protein 2-acetyltributylcitrate promotes the reaction [NCOA1 protein binds to NR1I2 protein]; 2-acetyltributylcitrate promotes the reaction [NCOA2 protein binds to NR1I2 protein]; 2-acetyltributylcitrate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA]
CTD
PMID:21742782
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nsdhl
NAD(P) dependent steroid dehydrogenase-like
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of NSDHL mRNA
CTD
PMID:37055963
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
G
Ptgds
prostaglandin D2 synthase
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of PTGDS mRNA
CTD
PMID:37055963
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
G
Scd
stearoyl-CoA desaturase
multiple interactions increases expression
ISO
[2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SCD1 mRNA 2-acetyltributylcitrate results in increased expression of SCD1 mRNA; 2-acetyltributylcitrate results in increased expression of SCD1 protein
CTD
PMID:37055963
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sqle
squalene epoxidase
decreases expression
ISO
2-acetyltributylcitrate results in decreased expression of SQLE mRNA
CTD
PMID:37055963
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases cleavage decreases expression
ISO
2-acetyltributylcitrate results in decreased cleavage of SREBF1 protein 2-acetyltributylcitrate results in decreased expression of SREBF1 mRNA
CTD
PMID:37055963
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Capsaicin results in increased expression of ABCA1 protein]
CTD
PMID:21908651
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Agt
angiotensinogen
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [AGT protein modified form results in increased abundance of Superoxides]
CTD
PMID:12606818
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Rotenone results in decreased phosphorylation of AKT1 protein]
CTD
PMID:25433145
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Atf6
activating transcription factor 6
increases expression multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of ATF6 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6 protein]
CTD
PMID:28181380
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atf6b
activating transcription factor 6 beta
multiple interactions increases expression
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6B protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of ATF6B protein
CTD
PMID:28181380
NCBI chr20:4,090,921...4,098,920
Ensembl chr20:4,090,921...4,098,894
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Diclofenac results in increased activity of BID protein]
CTD
PMID:18191430
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Cacna1e
calcium voltage-gated channel subunit alpha1 E
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid affects the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]]
CTD
PMID:12663092
NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450
G
Capn1
calpain 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CAPN1 protein]
CTD
PMID:28181380
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
G
Capn2
calpain 2
multiple interactions increases expression
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CAPN2 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of CAPN2 protein
CTD
PMID:28181380
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Casp1
caspase 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP1 protein]
CTD
PMID:36308466
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
multiple interactions increases expression
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CASP12 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of CASP12 protein
CTD
PMID:28181380
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased activity of CASP3 protein]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Pilocarpine results in increased activity of CASP3 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [GW 7845 results in increased activity of CASP3 protein]; [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]
CTD
PMID:19927300 PMID:20810541 PMID:28181380 PMID:29111403
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
increases expression multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of CASP4 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CASP4 protein]
CTD
PMID:28181380
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp8
caspase 8
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]; [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]
CTD
PMID:29111403
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Creb1
cAMP responsive element binding protein 1
decreases phosphorylation
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in decreased phosphorylation of CREB1 protein
CTD
PMID:21443188
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crebbp
CREB binding protein
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]
CTD
PMID:21443188
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Cycs
cytochrome c, somatic
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [GW 7845 affects the localization of CYCS protein]
CTD
PMID:20810541
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of DDIT3 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; [Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] inhibits the reaction [Cadmium results in increased expression of DDIT3 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of DDIT3 protein]
CTD
PMID:28181380 PMID:29111403
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions increases expression
ISO
[fisetin co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] results in decreased expression of EIF2AK3 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of EIF2AK3 protein
CTD
PMID:28181380
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Ionomycin results in increased expression of FOS mRNA]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [PDGFB protein results in increased expression of FOS mRNA]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA]
CTD
PMID:9650640
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]
CTD
PMID:25433145
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]
CTD
PMID:21443188
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Humic Substances results in increased expression of HSP90AA1 protein]
CTD
PMID:23836447
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Humic Substances results in increased expression of HSP90AB1 protein]
CTD
PMID:23836447
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of HSPA5 protein]
CTD
PMID:28181380
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [tributyltin results in increased expression of IL1A protein]
CTD
PMID:9221826
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein]
CTD
PMID:36308466
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased secretion of IL4 protein]
CTD
PMID:20371970
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Lrp1
LDL receptor related protein 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein]
CTD
PMID:21908651
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [cupric chloride results in increased lipidation of MAP1LC3B protein]
CTD
PMID:37981210
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MAPK3 mRNA]
CTD
PMID:28836330
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Pilocarpine results in increased activity of MAPK8 protein]
CTD
PMID:19927300
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Acrolein results in increased expression of MMP9 protein]
CTD
PMID:19371603
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nefl
neurofilament light chain
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA]
CTD
PMID:31969611
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid affects the localization of NFE2L2 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]
CTD
PMID:21443188
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NLRP3 protein]
CTD
PMID:36308466
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nos3
nitric oxide synthase 3
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Humic Substances results in increased expression of and results in increased phosphorylation of NOS3 protein]
CTD
PMID:23836447
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased activity of PARP1 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]
CTD
PMID:24752504 PMID:29111403
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdgfb
platelet derived growth factor subunit B
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [PDGFB protein results in increased expression of FOS mRNA]
CTD
PMID:9650640
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [diphenylditelluride results in decreased expression of PRKACA protein]
CTD
PMID:21863293
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Rbfox3
RNA binding fox-1 homolog 3
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [cupric chloride results in decreased expression of RBFOX3 protein]
CTD
PMID:37981210
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions decreases phosphorylation
ISO
oxophenylarsine inhibits the reaction [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in decreased phosphorylation of RPS6KB1 protein]
CTD
PMID:16183647
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Sct
secretin
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Ursodeoxycholic Acid analog results in increased activity of SCT]
CTD
PMID:22194894
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
G
Snca
synuclein alpha
multiple interactions
EXP
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Rotenone results in increased expression of and results in increased phosphorylation of SNCA protein]
CTD
PMID:25433145
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Sqstm1
sequestosome 1
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [cupric chloride results in increased expression of SQSTM1 protein]
CTD
PMID:37981210
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Tnf
tumor necrosis factor
multiple interactions
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein]
CTD
PMID:36308466
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Xiap
X-linked inhibitor of apoptosis
decreases degradation
ISO
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in decreased degradation of XIAP protein
CTD
PMID:16223472
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Acaca
acetyl-CoA carboxylase alpha
increases phosphorylation
EXP
chicoric acid results in increased phosphorylation of ACACA protein
CTD
PMID:24244361
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
chicoric acid inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]
CTD
PMID:24244361
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Cs
citrate synthase
increases activity
EXP
chicoric acid results in increased activity of CS protein
CTD
PMID:24244361
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Ins1
insulin 1
multiple interactions
EXP
chicoric acid inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; chicoric acid inhibits the reaction [INS1 protein results in increased phosphorylation of MTOR protein]
CTD
PMID:24244361
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
EXP
chicoric acid inhibits the reaction [INS1 protein results in increased phosphorylation of MTOR protein]
CTD
PMID:24244361
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Ppargc1a
PPARG coactivator 1 alpha
increases expression
EXP
chicoric acid results in increased expression of PPARGC1A mRNA
CTD
PMID:24244361
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Sod2
superoxide dismutase 2
increases expression
EXP
chicoric acid results in increased expression of SOD2 protein
CTD
PMID:24244361
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Cpox
coproporphyrinogen oxidase
decreases carboxylation multiple interactions
ISO
CPOX protein results in decreased carboxylation of coproporphyrinogen III Mercury inhibits the reaction [CPOX protein results in decreased carboxylation of coproporphyrinogen III]
CTD
PMID:19339664
NCBI chr11:41,936,585...41,946,568
Ensembl chr11:41,936,591...41,946,746
G
Agt
angiotensinogen
multiple interactions
EXP
[Egtazic Acid co-treated with Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone] inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]
CTD
PMID:18854758
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO EXP
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of AKT1 protein]
CTD
PMID:21544200
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Atg7
autophagy related 7
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]
CTD
PMID:30266318
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
G
Becn1
beclin 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of BECN1 protein]
CTD
PMID:30266318
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
C5
complement C5
multiple interactions
ISO
[Egtazic Acid co-treated with Asbestos, Crocidolite] results in increased cleavage of C5 protein; [Egtazic Acid co-treated with Asbestos, Serpentine] results in increased cleavage of C5 protein
CTD
PMID:10777245
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
multiple interactions
EXP
Egtazic Acid inhibits the reaction [LIF protein results in increased phosphorylation of CAMK2A protein]
CTD
PMID:11073891
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Capn1
calpain 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of CAPN1 protein]
CTD
PMID:26998625
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
G
Capn2
calpain 2
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of CAPN2 protein]
CTD
PMID:26998625
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Casp12
caspase 12
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP12 protein]; Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of CASP12 protein]
CTD
PMID:20079824 PMID:26998625
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
multiple interactions
ISO EXP
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Egtazic Acid promotes the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein] [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP3 protein]
CTD
PMID:19837105 PMID:20020783 PMID:21544200 PMID:26998625 PMID:29111403
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions
ISO
[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]
CTD
PMID:29111403
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cck
cholecystokinin
multiple interactions
ISO
Egtazic Acid inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein]
CTD
PMID:25787141
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of CCL5 protein]
CTD
PMID:21245013
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cfl1
cofilin 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Capsaicin results in decreased phosphorylation of and results in increased activity of CFL1 protein]; Egtazic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of and results in increased activity of CFL1 protein]
CTD
PMID:17303079
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Cga
glycoprotein hormones, alpha polypeptide
multiple interactions
EXP ISO
[Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester] inhibits the reaction [[CGA protein co-treated with Atrazine] results in increased expression of STAR mRNA] Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]
CTD
PMID:27554787 PMID:28731686
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
G
Col6a3
collagen type VI alpha 3 chain
multiple interactions
ISO
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]; [Cyclosporine co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]
CTD
PMID:18435905
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Creb1
cAMP responsive element binding protein 1
decreases phosphorylation
ISO
Egtazic Acid results in decreased phosphorylation of CREB1 protein
CTD
PMID:21443188
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crebbp
CREB binding protein
multiple interactions
ISO
Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]
CTD
PMID:21443188
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Crk
CRK proto-oncogene, adaptor protein
multiple interactions
EXP
Egtazic Acid inhibits the reaction [Sincalide results in increased phosphorylation of CRK protein]
CTD
PMID:16187300
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
Egtazic Acid inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; Egtazic Acid inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]
CTD
PMID:18346843
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of CXCL10 protein]
CTD
PMID:21245013
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of CYP11A1 mRNA]
CTD
PMID:28731686 PMID:35931855
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein]
CTD
PMID:9143349
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Amiodarone results in increased expression of DDIT3] [Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]
CTD
PMID:21292685 PMID:29111403
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Egr1
early growth response 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of EGR1 protein]
CTD
PMID:29149324
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein]
CTD
PMID:21544200
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of FOS protein]
CTD
PMID:29149324
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
ISO
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of FSHB protein]
CTD
PMID:28731686
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]]
CTD
PMID:15627515
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
multiple interactions
ISO
Egtazic Acid inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]]
CTD
PMID:15627515
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
G
Gcg
glucagon
multiple interactions
ISO
Egtazic Acid inhibits the reaction [deoxynivalenol results in increased secretion of GCG protein alternative form]
CTD
PMID:25787141
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
G
Gfap
glial fibrillary acidic protein
multiple interactions
EXP
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein]
CTD
PMID:21879721
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gnal
G protein subunit alpha L
multiple interactions
ISO
Egtazic Acid inhibits the reaction [[GNAL protein results in increased susceptibility to azelaic acid] which results in increased activity of OR55B4 protein]; Egtazic Acid inhibits the reaction [[GNAL protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]; Egtazic Acid inhibits the reaction [GNAL protein results in increased susceptibility to azelaic acid]; Egtazic Acid inhibits the reaction [GNAL protein results in increased susceptibility to citronellal]; Egtazic Acid inhibits the reaction [GNAL protein results in increased susceptibility to Isoproterenol]
CTD
PMID:15598656
NCBI chr18:60,622,311...60,762,599
Ensembl chr18:60,622,311...60,762,599
G
Gnas
GNAS complex locus
multiple interactions
ISO
Egtazic Acid inhibits the reaction [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]; Egtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to citronellal]; Egtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to Isoproterenol]
CTD
PMID:15598656
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; Egtazic Acid inhibits the reaction [Curcumin results in increased expression of HMOX1 protein]
CTD
PMID:18357586 PMID:21443188
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
[Egtazic Acid co-treated with Paraoxon] results in increased expression of HSPA5 protein
CTD
PMID:26998625
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Igf1
insulin-like growth factor 1
decreases response to substance
ISO
Egtazic Acid results in decreased susceptibility to IGF1 protein
CTD
PMID:16485066
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf2
insulin-like growth factor 2
decreases response to substance
ISO
Egtazic Acid results in decreased susceptibility to IGF2 protein
CTD
PMID:16485066
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Il6
interleukin 6
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Capsaicin results in increased expression of IL6 mRNA]
CTD
PMID:16173059
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of JUN protein]
CTD
PMID:29149324
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
Egtazic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein]
CTD
PMID:15865434
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Kif5a
kinesin family member 5A
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Cadmium Chloride inhibits the reaction [KIF5A protein results in increased hydrolysis of Adenosine Triphosphate]]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in decreased activity of KIF5A protein]; Egtazic Acid inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]
CTD
PMID:24239783 PMID:24853401
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
G
Lhb
luteinizing hormone subunit beta
multiple interactions
ISO
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of LHB protein]
CTD
PMID:28731686
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lif
LIF, interleukin 6 family cytokine
multiple interactions
EXP
Egtazic Acid inhibits the reaction [LIF protein results in increased phosphorylation of CAMK2A protein]
CTD
PMID:11073891
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of and results in increased phosphorylation of MAPK1 protein]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]; Egtazic Acid inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK1 protein]; Egtazic Acid inhibits the reaction [Thapsigargin results in increased activity of MAPK1 protein]; Egtazic Acid promotes the reaction [Tetracaine results in increased phosphorylation of MAPK1 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased localization of MAPK1 protein modified form]
CTD
PMID:11914123 PMID:11981161 PMID:19576918 PMID:21245013 PMID:21544200 PMID:29149324 More...
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
ISO EXP
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein]
CTD
PMID:21544200
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of and results in increased phosphorylation of MAPK3 protein]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]; Egtazic Acid inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK3 protein]; Egtazic Acid inhibits the reaction [Thapsigargin results in increased activity of MAPK3 protein]; Egtazic Acid promotes the reaction [Tetracaine results in increased phosphorylation of MAPK3 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased localization of MAPK3 protein modified form]
CTD
PMID:11914123 PMID:11981161 PMID:19576918 PMID:21245013 PMID:21544200 PMID:29149324 More...
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK8 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]
CTD
PMID:11981161 PMID:15254339 PMID:21544200
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]
CTD
PMID:11981161 PMID:15254339 PMID:21544200
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mmp1
matrix metallopeptidase 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased expression of MMP1 mRNA]; Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of MMP1 protein]
CTD
PMID:21245013
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO EXP
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein]
CTD
PMID:21544200
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nefl
neurofilament light chain
multiple interactions
EXP
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein]
CTD
PMID:21879721
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
multiple interactions
EXP
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFM protein]
CTD
PMID:21879721
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]
CTD
PMID:21443188
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos1
nitric oxide synthase 1
multiple interactions decreases expression
ISO
Egtazic Acid inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of NOS1 protein alternative form] Egtazic Acid results in decreased expression of NOS1 protein alternative form
CTD
PMID:16791854
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos3
nitric oxide synthase 3
decreases expression
ISO
Egtazic Acid results in decreased expression of NOS3; Egtazic Acid results in decreased expression of NOS3 mRNA
CTD
PMID:19837105 PMID:20020783
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Or6e1
olfactory receptor family 6 subfamily E member 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [[GNAL protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]; Egtazic Acid inhibits the reaction [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]
CTD
PMID:15598656
NCBI chr15:27,733,881...27,734,825
Ensembl chr15:27,729,827...27,736,945
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]
CTD
PMID:21544200 PMID:29111403
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdgfb
platelet derived growth factor subunit B
multiple interactions
ISO
Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
CTD
PMID:19576918
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pla2g1b
phospholipase A2 group IB
decreases activity
ISO
Egtazic Acid results in decreased activity of PLA2G1B protein
CTD
PMID:15528384
NCBI chr12:41,142,193...41,151,967
Ensembl chr12:41,142,200...41,153,226
G
Pon1
paraoxonase 1
decreases activity multiple interactions
ISO EXP
Egtazic Acid results in decreased activity of PON1 protein [Egtazic Acid results in decreased activity of PON1 protein] which affects the susceptibility to O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; [Egtazic Acid results in decreased activity of PON1 protein] which affects the susceptibility to oxamyl; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Aldicarb; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to methylparaoxon; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Paraoxon [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Aldicarb; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to methylparaoxon; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to oxamyl; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Paraoxon
CTD
PMID:27132127
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
multiple interactions
EXP
[Egtazic Acid co-treated with Calcium deficiency] results in increased expression of PPP1R15A mRNA
CTD
PMID:9878749
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prkca
protein kinase C, alpha
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein]
CTD
PMID:20172950
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Ptk2b
protein tyrosine kinase 2 beta
multiple interactions
EXP
Egtazic Acid inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of PTK2B protein]
CTD
PMID:16877402
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
multiple interactions
ISO
Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]
CTD
PMID:29149324
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Rps6
ribosomal protein S6
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6 protein]
CTD
PMID:21544200
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
EXP ISO
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein] Egtazic Acid inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:14516795 PMID:21544200
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Potassium Chloride results in increased secretion of SOD1 protein]
CTD
PMID:28085149
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Srr
serine racemase
multiple interactions
ISO EXP
[methyllycaconitine co-treated with Egtazic Acid] results in increased expression of SRR protein
CTD
PMID:24012499
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
G
Star
steroidogenic acute regulatory protein
multiple interactions
ISO EXP
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of STAR mRNA]; Egtazic Acid inhibits the reaction [Quercetin results in increased expression of STAR mRNA] [Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester] inhibits the reaction [[CGA protein co-treated with Atrazine] results in increased expression of STAR mRNA]
CTD
PMID:17332522 PMID:27554787 PMID:28731686 PMID:35931855
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Egtazic Acid inhibits the reaction [TNF protein results in increased transport of Chlorides]; Egtazic Acid inhibits the reaction [TNF protein results in increased transport of Potassium]
CTD
PMID:10783394
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
Egtazic Acid inhibits the reaction [Capsaicin results in increased expression of TNFSF10 mRNA]
CTD
PMID:22200406
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions
ISO
Egtazic Acid inhibits the reaction [anandamide binds to and results in increased activity of TRPV1 protein]; Egtazic Acid inhibits the reaction [Capsaicin binds to and results in increased activity of TRPV1 protein]; Egtazic Acid inhibits the reaction [N-(4-hydroxyphenyl)arachidonylamide binds to and results in increased activity of TRPV1 protein]
CTD
PMID:11278420
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Vim
vimentin
multiple interactions
EXP
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein]
CTD
PMID:21879721
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Ace
angiotensin I converting enzyme
decreases activity multiple interactions
ISO
Edetic Acid results in decreased activity of ACE protein Zinc Sulfate inhibits the reaction [Edetic Acid results in decreased activity of ACE protein]
CTD
PMID:28544013
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ache
acetylcholinesterase
multiple interactions
ISO
Edetic Acid results in decreased metabolism of and results in decreased secretion of ACHE protein
CTD
PMID:23047022
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ahr
aryl hydrocarbon receptor
multiple interactions
EXP
Edetic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]
CTD
PMID:1322109
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Anpep
alanyl aminopeptidase, membrane
multiple interactions
ISO
Edetic Acid promotes the reaction [1,10-phenanthroline results in decreased activity of ANPEP protein]
CTD
PMID:17109655
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Aplp1
amyloid beta precursor like protein 1
multiple interactions
ISO
Edetic Acid inhibits the reaction [Zinc affects the localization of APLP1 protein]
CTD
PMID:24855651
NCBI chr 1:85,696,880...85,707,215
Ensembl chr 1:85,696,882...85,707,155
G
Aplp2
amyloid beta precursor like protein 2
multiple interactions
ISO
Edetic Acid inhibits the reaction [Zinc affects the localization of APLP2 protein]
CTD
PMID:24855651
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
G
App
amyloid beta precursor protein
multiple interactions
ISO
Edetic Acid inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; Edetic Acid inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of Phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]
CTD
PMID:17964426
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Aspa
aspartoacylase
decreases activity
ISO
Edetic Acid results in decreased activity of ASPA protein
CTD
PMID:17027983
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
multiple interactions
EXP
[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein; Butylated Hydroxytoluene inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein]; dicarbine inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein]
CTD
PMID:12870653
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
G
Bmp4
bone morphogenetic protein 4
multiple interactions
ISO
[Edetic Acid inhibits the reaction [Calcium binds to MGP protein]] inhibits the reaction [MGP protein binds to BMP4 protein]
CTD
PMID:18369157
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Casp1
caspase 1
multiple interactions
ISO
Edetic Acid inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein]
CTD
PMID:25929180
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Cat
catalase
multiple interactions
ISO
CAT inhibits the reaction [[XDH protein co-treated with Edetic Acid analog] results in increased oxidation of Uroporphyrinogens]
CTD
PMID:1567206
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cp
ceruloplasmin
multiple interactions
ISO
Edetic Acid inhibits the reaction [CP protein results in increased oxidation of 3-carboxy-2,2,5,5-tetramethylpyrrolidin-1-yloxyl]
CTD
PMID:22824865
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
EXP
Edetic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]
CTD
PMID:1322109
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
Edetic Acid inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein]
CTD
PMID:9143349
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dld
dihydrolipoamide dehydrogenase
multiple interactions
ISO
Edetic Acid inhibits the reaction [Cadmium Chloride results in decreased activity of and results in increased phosphorylation of DLD protein]
CTD
PMID:29158198
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
G
Dspp
dentin sialophosphoprotein
affects localization
EXP
Edetic Acid affects the localization of DSPP protein
CTD
PMID:23525114
NCBI chr14:5,565,562...5,571,669
Ensembl chr14:5,565,629...5,571,672
G
Dusp23
dual specificity phosphatase 23
multiple interactions
ISO
Edetic Acid inhibits the reaction [DUSP23 protein results in decreased phosphorylation of nitrophenylphosphate]
CTD
PMID:15147733
NCBI chr13:85,097,899...85,100,054
Ensembl chr13:85,097,899...85,100,093
G
Enpp7
ectonucleotide pyrophosphatase/phosphodiesterase 7
multiple interactions
ISO
Edetic Acid inhibits the reaction [Zinc results in decreased activity of ENPP7 protein]
CTD
PMID:12885774
NCBI chr10:104,242,169...104,247,185
Ensembl chr10:104,242,223...104,246,589
G
Esr1
estrogen receptor 1
increases expression
ISO
Edetic Acid results in increased expression of ESR1 mRNA
CTD
PMID:22083529
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Gh1
growth hormone 1
multiple interactions
EXP
Edetic Acid promotes the reaction [Triiodothyronine results in increased expression of GH1 mRNA]
CTD
PMID:10720163
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Igfbp5
insulin-like growth factor binding protein 5
decreases degradation
EXP
Edetic Acid results in decreased degradation of IGFBP5 protein
CTD
PMID:8894652
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Il6
interleukin 6
multiple interactions
ISO
Edetic Acid inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]
CTD
PMID:11238657
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Itgam
integrin subunit alpha M
increases expression
ISO
Edetic Acid results in increased expression of ITGAM protein
CTD
PMID:8595612
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
Edetic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein]
CTD
PMID:15865434
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Mbp
myelin basic protein
affects expression
EXP
Edetic Acid affects the expression of MBP mRNA
CTD
PMID:22954530
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mgp
matrix Gla protein
multiple interactions
ISO
[Edetic Acid inhibits the reaction [Calcium binds to MGP protein]] inhibits the reaction [MGP protein binds to BMP4 protein]; Edetic Acid inhibits the reaction [Calcium binds to MGP protein]
CTD
PMID:18369157
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mmp8
matrix metallopeptidase 8
decreases activity
ISO
Edetic Acid results in decreased activity of MMP8 protein
CTD
PMID:15057751
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mt3
metallothionein 3
increases alkylation affects metabolic processing
ISO
Edetic Acid results in increased alkylation of MT3 protein MT3 protein polymorphism affects the metabolism of Edetic Acid
CTD
PMID:12383939 PMID:14983064
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Neil1
nei-like DNA glycosylase 1
multiple interactions
ISO
[tris(2-carboxyethyl)phosphine co-treated with Edetic Acid] inhibits the reaction [Copper results in decreased activity of NEIL1 protein]; Edetic Acid inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]
CTD
PMID:20622253
NCBI chr 8:57,550,142...57,556,884
Ensembl chr 8:57,550,147...57,556,258
G
Optc
opticin
multiple interactions
ISO
Edetic Acid inhibits the reaction [Oxygen deficiency results in increased degradation of OPTC protein]; Edetic Acid inhibits the reaction [VEGFA protein results in increased degradation of OPTC protein]
CTD
PMID:22534113
NCBI chr13:45,353,954...45,368,254
Ensembl chr13:45,355,148...45,365,237
G
Pgp
phosphoglycolate phosphatase
decreases activity
ISO
Edetic Acid results in decreased activity of PGP protein
CTD
PMID:24338473
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,494,291...13,497,858
G
Plat
plasminogen activator, tissue type
multiple interactions
ISO
Edetic Acid inhibits the reaction [Zinc results in increased expression of PLAT mRNA]; Edetic Acid inhibits the reaction [Zinc results in increased expression of PLAT protein]; Edetic Acid inhibits the reaction [Zinc results in increased secretion of PLAT protein]
CTD
PMID:21615740
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plg
plasminogen
multiple interactions
ISO
Edetic Acid inhibits the reaction [Zinc results in increased expression of PLG mRNA]; Edetic Acid inhibits the reaction [Zinc results in increased expression of PLG protein]
CTD
PMID:21615740
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
G
Prl
prolactin
multiple interactions
ISO
Edetic Acid inhibits the reaction [PRL protein binds to PRLR protein]
CTD
PMID:6197504
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prlr
prolactin receptor
multiple interactions
ISO
Edetic Acid inhibits the reaction [PRL protein binds to PRLR protein]
CTD
PMID:6197504
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prnp
prion protein
multiple interactions
ISO
Edetic Acid inhibits the reaction [[Hydrogen Peroxide co-treated with Copper] results in increased cleavage of PRNP protein]; Edetic Acid inhibits the reaction [[Hydrogen Peroxide co-treated with Iron] results in increased cleavage of PRNP protein]
CTD
PMID:16595185
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
S100a2
S100 calcium binding protein A2
multiple interactions
ISO
Edetic Acid inhibits the reaction [Copper promotes the reaction [S100A2 protein binds to S100A2 protein]]; Edetic Acid inhibits the reaction [S100A2 protein binds to S100A2 protein]
CTD
PMID:21924240
NCBI chr 2:176,077,081...176,078,325
G
S100a4
S100 calcium-binding protein A4
multiple interactions
ISO
Edetic Acid inhibits the reaction [Copper promotes the reaction [S100A4 protein binds to S100A4 protein]]
CTD
PMID:21924240
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
Sell
selectin L
decreases expression
ISO
Edetic Acid results in decreased expression of SELL protein
CTD
PMID:8595612
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc30a10
solute carrier family 30, member 10
increases expression multiple interactions
ISO
Edetic Acid results in increased expression of SLC30A10 mRNA; Edetic Acid results in increased expression of SLC30A10 protein Edetic Acid inhibits the reaction [SLC30A10 gene mutant form results in increased abundance of Manganese]
CTD
PMID:22341971 PMID:22926781
NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103
G
Sptan1
spectrin, alpha, non-erythrocytic 1
multiple interactions
EXP
Edetic Acid inhibits the reaction [Calcium results in increased cleavage of SPTAN1 protein]
CTD
PMID:17069801
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Srr
serine racemase
multiple interactions
ISO
Adenosine Triphosphate inhibits the reaction [Edetic Acid inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]]; Edetic Acid inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]
CTD
PMID:27387750
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
G
Tnf
tumor necrosis factor
increases expression
ISO
Edetic Acid results in increased expression of TNF protein
CTD
PMID:29953848
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions
ISO
Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP53 protein] inhibits the reaction [TP53 protein binds to TP53 gene]]; Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP63 protein] inhibits the reaction [TP63 protein binds to TP53 gene]]; Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene]]
CTD
PMID:25446071
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
multiple interactions
ISO
Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP63 protein] inhibits the reaction [TP63 protein binds to TP53 gene]]
CTD
PMID:25446071
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tp73
tumor protein p73
multiple interactions
ISO
Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene]]
CTD
PMID:25446071
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions
ISO
Edetic Acid inhibits the reaction [Capsaicin promotes the reaction [TRPV1 protein results in increased uptake of Calcium]]
CTD
PMID:17442041
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Txnrd1
thioredoxin reductase 1
increases activity multiple interactions
ISO
Edetic Acid results in increased activity of TXNRD1 protein Zinc inhibits the reaction [Edetic Acid results in increased activity of TXNRD1 protein]
CTD
PMID:16774913
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd3
thioredoxin reductase 3
increases activity multiple interactions
ISO
Edetic Acid results in increased activity of TXNRD3 protein Zinc inhibits the reaction [Edetic Acid results in increased activity of TXNRD3 protein]
CTD
PMID:16774913
NCBI chr 4:122,072,548...122,112,493
Ensembl chr 4:122,072,548...122,112,491
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
Edetic Acid inhibits the reaction [VEGFA protein results in increased degradation of OPTC protein]
CTD
PMID:22534113
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
multiple interactions
ISO
[XDH protein co-treated with Edetic Acid analog] results in increased oxidation of Uroporphyrinogens; CAT inhibits the reaction [[XDH protein co-treated with Edetic Acid analog] results in increased oxidation of Uroporphyrinogens]
CTD
PMID:1567206
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
A2m
alpha-2-macroglobulin
decreases expression
ISO
fumonisin B1 results in decreased expression of PZP mRNA
CTD
PMID:16221962
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
ISO
fumonisin B1 results in decreased expression of AASS mRNA
CTD
PMID:16221962
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
EXP ISO
fumonisin B1 inhibits the reaction [nickel chloride results in increased expression of ABCB1 protein] fumonisin B1 inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]
CTD
PMID:24448832 PMID:34915026
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb4
ATP binding cassette subfamily B member 4
increases expression
ISO
fumonisin B1 results in increased expression of ABCB4 mRNA
CTD
PMID:16221962
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcg8
ATP binding cassette subfamily G member 8
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA
CTD
PMID:30448865
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Ackr3
atypical chemokine receptor 3
decreases expression
ISO
fumonisin B1 results in decreased expression of ACKR3 mRNA
CTD
PMID:27757495
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Acot2
acyl-CoA thioesterase 2
increases expression
ISO
fumonisin B1 results in increased expression of ACOT2 mRNA
CTD
PMID:16221962
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of ACSL1 mRNA
CTD
PMID:16221962
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Actg1
actin, gamma 1
increases expression
ISO
fumonisin B1 results in increased expression of ACTG1 mRNA
CTD
PMID:16221962
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Actr2
actin related protein 2
increases expression
ISO
fumonisin B1 results in increased expression of ACTR2 mRNA
CTD
PMID:16221962
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
G
Afm
afamin
decreases expression
ISO
fumonisin B1 results in decreased expression of AFM mRNA
CTD
PMID:16221962
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
G
Agt
angiotensinogen
multiple interactions decreases expression
ISO
fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 protein] fumonisin B1 results in decreased expression of AGT mRNA
CTD
PMID:16221962 PMID:18206046
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agxt
alanine--glyoxylate aminotransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of AGXT mRNA
CTD
PMID:16221962
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
G
Ahcy
adenosylhomocysteinase
decreases expression
ISO
fumonisin B1 results in decreased expression of AHCY mRNA
CTD
PMID:16221962
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Ahr
aryl hydrocarbon receptor
increases activity
EXP
fumonisin B1 results in increased activity of AHR protein
CTD
PMID:25449202
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ahsg
alpha-2-HS-glycoprotein
increases expression
ISO
fumonisin B1 results in increased expression of AHSG mRNA
CTD
PMID:16221962
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
G
Akr1a1
aldo-keto reductase family 1 member A1
increases expression
ISO
fumonisin B1 results in increased expression of AKR1A1 mRNA
CTD
PMID:16221962
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Akr1b7
aldo-keto reductase family 1, member B7
increases expression
ISO
fumonisin B1 results in increased expression of AKR1B7 mRNA
CTD
PMID:16221962
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
G
Alcam
activated leukocyte cell adhesion molecule
increases expression
ISO
fumonisin B1 results in increased expression of ALCAM mRNA
CTD
PMID:16221962
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
ISO
fumonisin B1 results in increased expression of ALDH1A1 mRNA
CTD
PMID:16221962
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
increases expression
ISO
fumonisin B1 results in increased expression of ALDH3A2 mRNA
CTD
PMID:16221962
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldob
aldolase, fructose-bisphosphate B
decreases expression
ISO
fumonisin B1 results in decreased expression of ALDOB mRNA
CTD
PMID:16221962
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
ISO
fumonisin B1 results in increased expression of ALDOA mRNA
CTD
PMID:16221962
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alkbh5
alkB homolog 5, RNA demethylase
decreases expression
ISO
fumonisin B1 results in decreased expression of ALKBH5 mRNA
CTD
PMID:33496827
NCBI chr10:45,344,888...45,366,331
Ensembl chr10:45,343,395...45,366,331
G
Anxa2
annexin A2
increases expression
ISO
fumonisin B1 results in increased expression of ANXA2 mRNA
CTD
PMID:16221962
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Anxa5
annexin A5
increases expression
ISO
fumonisin B1 results in increased expression of ANXA5 mRNA
CTD
PMID:16221962
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Apaf1
apoptotic peptidase activating factor 1
multiple interactions
ISO
[fumonisin B1 co-treated with ochratoxin A] results in increased expression of APAF1 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA]
CTD
PMID:36397609
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apcs
amyloid P component, serum
decreases expression
ISO
fumonisin B1 results in decreased expression of APCS mRNA
CTD
PMID:16221962
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
G
Apoa4
apolipoprotein A4
increases expression
ISO
fumonisin B1 results in increased expression of APOA4 mRNA
CTD
PMID:16221962
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apoc4
apolipoprotein C4
decreases expression
ISO
fumonisin B1 results in decreased expression of APOC4 mRNA
CTD
PMID:16221962
NCBI chr 1:79,335,745...79,339,942
Ensembl chr 1:79,335,745...79,339,981
G
App
amyloid beta precursor protein
increases expression
ISO
fumonisin B1 results in increased expression of APP mRNA
CTD
PMID:16221962
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Arhgdia
Rho GDP dissociation inhibitor alpha
increases expression
ISO
fumonisin B1 results in increased expression of ARHGDIA mRNA
CTD
PMID:16221962
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Asl
argininosuccinate lyase
decreases expression
ISO
fumonisin B1 results in decreased expression of ASL mRNA
CTD
PMID:16221962
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
G
Atf4
activating transcription factor 4
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of ATF4 mRNA; fumonisin B1 results in increased expression of ATF4 protein EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of ATF4 protein]
CTD
PMID:31891755
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atox1
antioxidant 1 copper chaperone
increases expression
ISO
fumonisin B1 results in increased expression of ATOX1 mRNA
CTD
PMID:16221962
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
G
Atp6v0c
ATPase H+ transporting V0 subunit C
increases expression
ISO
fumonisin B1 results in increased expression of ATP6V0C mRNA
CTD
PMID:16221962
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
increases expression
ISO
fumonisin B1 results in increased expression of ATP6V0E mRNA
CTD
PMID:16221962
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
G
Atxn10
ataxin 10
increases expression
ISO
fumonisin B1 results in increased expression of ATXN10 mRNA
CTD
PMID:16221962
NCBI chr 7:116,441,768...116,565,093
Ensembl chr 7:116,441,613...116,565,087
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions affects expression increases expression
ISO
[fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased expression of BAX protein [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA] fumonisin B1 affects the expression of BAX mRNA fumonisin B1 results in increased expression of BAX protein fumonisin B1 results in increased expression of BAX mRNA; fumonisin B1 results in increased expression of BAX protein
CTD
PMID:25195822 PMID:31891755 PMID:35697133 PMID:36397609
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO
fumonisin B1 results in decreased expression of BCL2 mRNA; fumonisin B1 results in decreased expression of BCL2 protein fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein]
CTD
PMID:31891755 PMID:36397609
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of BHMT mRNA
CTD
PMID:16221962
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
C1qa
complement C1q A chain
increases expression
ISO
fumonisin B1 results in increased expression of C1QA mRNA
CTD
PMID:16221962
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qb
complement C1q B chain
increases expression
ISO
fumonisin B1 results in increased expression of C1QB mRNA
CTD
PMID:16221962
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
Calm2
calmodulin 2
increases expression
ISO
fumonisin B1 results in increased expression of CALM2 mRNA
CTD
PMID:16221962
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Capn2
calpain 2
increases expression
ISO
fumonisin B1 results in increased expression of CAPN2 mRNA
CTD
PMID:16221962
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Capns1
calpain, small subunit 1
increases expression
ISO
fumonisin B1 results in increased expression of CAPNS1 mRNA
CTD
PMID:16221962
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
G
Car3
carbonic anhydrase 3
decreases expression
ISO
fumonisin B1 results in decreased expression of CAR3 mRNA
CTD
PMID:16221962
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Car5a
carbonic anhydrase 5A
decreases expression
ISO
fumonisin B1 results in decreased expression of CAR5A mRNA
CTD
PMID:16221962
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
G
Casp1
caspase 1
increases cleavage multiple interactions increases expression
ISO
fumonisin B1 results in increased cleavage of CASP1 protein deoxynivalenol promotes the reaction [fumonisin B1 results in increased cleavage of CASP1 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased cleavage of CASP1 protein] fumonisin B1 results in increased expression of CASP1 mRNA
CTD
PMID:36309173
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases expression multiple interactions decreases expression
ISO
fumonisin B1 results in increased expression of CASP3 mRNA [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP3 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA] fumonisin B1 results in decreased expression of CASP3 mRNA fumonisin B1 results in decreased expression of and results in increased cleavage of CASP3 protein
CTD
PMID:31891755 PMID:35697133 PMID:36397609
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions
ISO
[fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased expression of CASP7 protein modified form
CTD
PMID:25195822
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
multiple interactions
ISO
[fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP9 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA]
CTD
PMID:36397609
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases activity decreases expression multiple interactions
EXP ISO
fumonisin B1 results in increased activity of CAT protein fumonisin B1 results in decreased expression of CAT mRNA [Aflatoxin B1 co-treated with fumonisin B1] results in increased activity of CAT protein
CTD
PMID:20015463 PMID:28181396 PMID:35697133
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
fumonisin B1 results in increased expression of CCL20 mRNA
CTD
PMID:27757495
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
fumonisin B1 results in increased expression of CCL4 mRNA
CTD
PMID:27757495
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
fumonisin B1 results in increased expression of CCL5 mRNA
CTD
PMID:27757495
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccnd1
cyclin D1
increases expression
ISO
fumonisin B1 results in increased expression of CCND1 mRNA
CTD
PMID:16221962
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccr1
C-C motif chemokine receptor 1
increases expression
ISO
fumonisin B1 results in increased expression of CCR1 mRNA
CTD
PMID:27757495
NCBI chr 8:123,556,286...123,561,841
G
Ccr4
C-C motif chemokine receptor 4
increases expression
ISO
fumonisin B1 results in increased expression of CCR4 mRNA
CTD
PMID:27757495
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Cd164
CD164 molecule
increases expression
ISO
fumonisin B1 results in increased expression of CD164 mRNA
CTD
PMID:16221962
NCBI chr20:45,024,051...45,035,628
Ensembl chr20:45,023,973...45,035,634
G
Cd5l
Cd5 molecule-like
increases expression
ISO
fumonisin B1 results in increased expression of CD5L mRNA
CTD
PMID:16221962
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
G
Cd63
Cd63 molecule
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of CD63 mRNA [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA
CTD
PMID:16221962 PMID:30448865
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
G
Cd81
Cd81 molecule
increases expression
ISO
fumonisin B1 results in increased expression of CD81 mRNA
CTD
PMID:16221962
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
G
Cd9
CD9 molecule
increases expression
ISO
fumonisin B1 results in increased expression of CD9 mRNA
CTD
PMID:16221962
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdc42
cell division cycle 42
increases expression
ISO
fumonisin B1 results in increased expression of CDC42 mRNA
CTD
PMID:16221962
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of CDKN1A mRNA [fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased expression of CDKN1A protein
CTD
PMID:16221962 PMID:25195822
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression
ISO
fumonisin B1 results in increased expression of CDKN2A mRNA
CTD
PMID:16221962
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
increases expression
ISO
fumonisin B1 results in increased expression of CDKN2B mRNA
CTD
PMID:16221962
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cdv3
carnitine deficiency-associated gene expressed in ventricle 3
increases expression
ISO
fumonisin B1 results in increased expression of CDV3 mRNA
CTD
PMID:16221962
NCBI chr 8:103,934,006...103,947,173
Ensembl chr 8:103,933,996...103,947,192
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
ISO
fumonisin B1 results in decreased expression of CEACAM1 mRNA
CTD
PMID:16221962
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
G
Cers2
ceramide synthase 2
multiple interactions
ISO
[fumonisin B1 co-treated with Particulate Matter] results in increased expression of CERS2 mRNA; [fumonisin B1 co-treated with Vehicle Emissions] results in increased expression of CERS2 mRNA
CTD
PMID:27376354
NCBI chr 2:182,890,527...182,898,805
Ensembl chr 2:182,890,493...182,933,314
G
Ces1d
carboxylesterase 1D
increases expression
ISO
fumonisin B1 results in increased expression of CES1 mRNA
CTD
PMID:16221962
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Ces3a
carboxylesterase 3a
decreases expression
ISO
fumonisin B1 results in decreased expression of CES3 mRNA
CTD
PMID:16221962
NCBI chr19:32,992,386...33,000,562
G
Cfh
complement factor H
decreases expression
ISO
fumonisin B1 results in decreased expression of CFH mRNA
CTD
PMID:16221962
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Cfl1
cofilin 1
increases expression
ISO
fumonisin B1 results in increased expression of CFL1 mRNA
CTD
PMID:16221962
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Cfp
complement factor properdin
increases expression
ISO
fumonisin B1 results in increased expression of CFP mRNA
CTD
PMID:16221962
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
G
Cldn3
claudin 3
decreases expression multiple interactions
ISO
fumonisin B1 results in decreased expression of CLDN3 mRNA illite inhibits the reaction [fumonisin B1 results in decreased expression of CLDN3 mRNA]
CTD
PMID:27153755
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
G
Cldn4
claudin 4
decreases expression multiple interactions
ISO
fumonisin B1 results in decreased expression of CLDN4 mRNA illite inhibits the reaction [fumonisin B1 results in decreased expression of CLDN4 mRNA]
CTD
PMID:27153755
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
G
Clec4f
C-type lectin domain family 4, member F
increases expression
ISO
fumonisin B1 results in increased expression of CLEC4F mRNA
CTD
PMID:16221962
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
G
Cltc
clathrin heavy chain
increases expression
ISO
fumonisin B1 results in increased expression of CLTC mRNA
CTD
PMID:16221962
NCBI chr10:71,517,661...71,574,591
Ensembl chr10:71,517,663...71,573,737
G
Clu
clusterin
increases expression
ISO
fumonisin B1 results in increased expression of CLU mRNA
CTD
PMID:16221962
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Col18a1
collagen type XVIII alpha 1 chain
decreases expression
ISO
fumonisin B1 results in decreased expression of COL18A1 mRNA
CTD
PMID:16221962
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA
CTD
PMID:30448865
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA
CTD
PMID:30448865
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Cox7b
cytochrome c oxidase subunit 7B
decreases expression
ISO
fumonisin B1 results in decreased expression of COX7B mRNA
CTD
PMID:16221962
NCBI chr X:71,083,486...71,089,733
Ensembl chr X:71,083,456...71,089,732
G
Cp
ceruloplasmin
increases expression
ISO
fumonisin B1 results in increased expression of CP mRNA
CTD
PMID:16221962
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpo
carboxypeptidase O
decreases expression
ISO
fumonisin B1 results in decreased expression of CPO mRNA
CTD
PMID:16221962
NCBI chr 9:65,319,996...65,338,250
G
Crp
C-reactive protein
decreases expression
ISO
fumonisin B1 results in decreased expression of CRP mRNA
CTD
PMID:16221962
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cstb
cystatin B
increases expression
ISO
fumonisin B1 results in increased expression of CSTB mRNA
CTD
PMID:16221962
NCBI chr20:10,245,462...10,247,505
Ensembl chr20:10,245,462...10,247,526
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
increases expression
ISO
fumonisin B1 results in increased expression of CTLA4 mRNA
CTD
PMID:27757495
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Ctnna1
catenin alpha 1
increases expression
ISO
fumonisin B1 results in increased expression of CTNNA1 mRNA
CTD
PMID:16221962
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
G
Ctnnb1
catenin beta 1
increases expression
ISO
fumonisin B1 results in increased expression of CTNNB1 mRNA
CTD
PMID:16221962
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctsb
cathepsin B
increases expression
ISO
fumonisin B1 results in increased expression of CTSB mRNA
CTD
PMID:16221962
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsd
cathepsin D
increases expression
ISO
fumonisin B1 results in increased expression of CTSD mRNA
CTD
PMID:16221962
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Ctsl
cathepsin L
increases expression
ISO
fumonisin B1 results in increased expression of CTSL mRNA
CTD
PMID:16221962
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Ctss
cathepsin S
increases expression
ISO
fumonisin B1 results in increased expression of CTSS mRNA
CTD
PMID:16221962
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
ISO
fumonisin B1 results in decreased expression of CXCL1 mRNA
CTD
PMID:27757495
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl11
C-X-C motif chemokine ligand 11
increases expression
ISO
fumonisin B1 results in increased expression of CXCL11 mRNA
CTD
PMID:27757495
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
ISO
fumonisin B1 results in decreased expression of CXCL12 mRNA
CTD
PMID:16221962
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl14
C-X-C motif chemokine ligand 14
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA
CTD
PMID:30448865
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
fumonisin B1 results in increased expression of CXCL2 mRNA
CTD
PMID:27757495
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression
ISO
fumonisin B1 results in decreased expression of CXCL1 mRNA
CTD
PMID:27757495
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
decreases expression
ISO
fumonisin B1 results in decreased expression of CXCR4 mRNA
CTD
PMID:27757495
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cxcr5
C-X-C motif chemokine receptor 5
decreases expression
ISO
fumonisin B1 results in decreased expression of CXCR5 mRNA
CTD
PMID:27757495
NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893
G
Cyb5b
cytochrome b5 type B
decreases expression
ISO
fumonisin B1 results in decreased expression of CYB5B mRNA
CTD
PMID:16221962
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
G
Cycs
cytochrome c, somatic
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of CYCS mRNA; fumonisin B1 results in increased expression of CYCS protein fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA]
CTD
PMID:31891755 PMID:36397609
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
ISO
fumonisin B1 results in decreased expression of CYP17A1 mRNA
CTD
PMID:16221962
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression increases activity
EXP
fumonisin B1 results in increased expression of CYP1A1 mRNA fumonisin B1 results in increased activity of CYP1A1 protein
CTD
PMID:25449202
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
fumonisin B1 results in increased expression of CYP1B1 mRNA; fumonisin B1 results in increased expression of CYP1B1 protein
CTD
PMID:24614526
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
increases expression
ISO
fumonisin B1 results in increased expression of CYP2A4 mRNA
CTD
PMID:16221962
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases expression
ISO
fumonisin B1 results in decreased expression of CYP2C29 mRNA
CTD
PMID:16221962
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
ISO
fumonisin B1 results in decreased expression of CYP2E1 mRNA
CTD
PMID:16221962
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases expression
ISO
fumonisin B1 results in decreased expression of CYP3A13 mRNA
CTD
PMID:16221962
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA
CTD
PMID:30448865
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of CYP8B1 mRNA
CTD
PMID:16221962
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Ddb1
damage-specific DNA binding protein 1
increases expression
ISO
fumonisin B1 results in increased expression of DDB1 mRNA
CTD
PMID:16221962
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of DDIT3 mRNA; fumonisin B1 results in increased expression of DDIT3 protein 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of DDIT3 protein]; EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of DDIT3 protein]; thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of DDIT3 protein]
CTD
PMID:31891755
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddt
D-dopachrome tautomerase
decreases expression
ISO
fumonisin B1 results in decreased expression of DDT mRNA
CTD
PMID:16221962
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
G
Ddx1
DEAD-box helicase 1
increases expression
ISO
fumonisin B1 results in increased expression of DDX1 mRNA
CTD
PMID:16221962
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
G
Degs1
delta(4)-desaturase, sphingolipid 1
increases expression
ISO
fumonisin B1 results in increased expression of DEGS1 mRNA
CTD
PMID:16221962
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
G
Diablo
diablo, IAP-binding mitochondrial protein
decreases expression
ISO
fumonisin B1 results in decreased expression of DIABLO protein
CTD
PMID:25800559
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dio1
iodothyronine deiodinase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of DIO1 mRNA
CTD
PMID:16221962
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dmbt1
deleted in malignant brain tumors 1
decreases expression
ISO
fumonisin B1 results in decreased expression of DMBT1 mRNA
CTD
PMID:16221962
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
G
Dmpk
DM1 protein kinase
increases expression
ISO
fumonisin B1 results in increased expression of DMPK mRNA
CTD
PMID:16221962
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
G
Dnmt1
DNA methyltransferase 1
decreases activity
ISO
fumonisin B1 results in decreased activity of DNMT1 protein
CTD
PMID:24280379
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
decreases activity
ISO
fumonisin B1 results in decreased activity of DNMT3A protein
CTD
PMID:24280379
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dnmt3b
DNA methyltransferase 3 beta
decreases activity
ISO
fumonisin B1 results in decreased activity of DNMT3B protein
CTD
PMID:24280379
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Dusp16
dual specificity phosphatase 16
increases expression
ISO
fumonisin B1 results in increased expression of DUSP16 mRNA
CTD
PMID:16221962
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Ebp
EBP, cholestenol delta-isomerase
decreases expression
ISO
fumonisin B1 results in decreased expression of EBP mRNA
CTD
PMID:16221962
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
G
Echs1
enoyl-CoA hydratase, short chain 1
decreases expression
ISO
fumonisin B1 results in decreased expression of ECHS1 mRNA
CTD
PMID:16221962
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of EIF2AK3 protein EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of ATF4 protein]; EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of DDIT3 protein]
CTD
PMID:31891755
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif6
eukaryotic translation initiation factor 6
increases expression
ISO
fumonisin B1 results in increased expression of EIF6 mRNA
CTD
PMID:16221962
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Elovl7
ELOVL fatty acid elongase 7
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA
CTD
PMID:30448865
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
G
Enpep
glutamyl aminopeptidase
decreases expression
ISO
fumonisin B1 results in decreased expression of ENPEP mRNA
CTD
PMID:16221962
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
increases expression
ISO
fumonisin B1 results in increased expression of ENTPD5 mRNA
CTD
PMID:16221962
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
fumonisin B1 results in increased expression of EPHX1 mRNA
CTD
PMID:16221962
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Esd
esterase D
increases expression
ISO
fumonisin B1 results in increased expression of ESD mRNA
CTD
PMID:16221962
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
F10
coagulation factor X
decreases expression
ISO
fumonisin B1 results in decreased expression of F10 mRNA
CTD
PMID:16221962
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F11r
F11 receptor
increases expression
ISO
fumonisin B1 results in increased expression of F11R mRNA
CTD
PMID:16221962
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
F7
coagulation factor VII
decreases expression
ISO
fumonisin B1 results in decreased expression of F7 mRNA
CTD
PMID:16221962
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Fabp1
fatty acid binding protein 1
decreases expression
ISO
fumonisin B1 results in decreased expression of FABP1 mRNA
CTD
PMID:16221962
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fah
fumarylacetoacetate hydrolase
decreases expression
ISO
fumonisin B1 results in decreased expression of FAH mRNA
CTD
PMID:16221962
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fas
Fas cell surface death receptor
multiple interactions
ISO
fumonisin B1 inhibits the reaction [[sorafenib co-treated with vorinostat] affects the localization of and results in increased activity of FAS protein]
CTD
PMID:18787411
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbp1
fructose-bisphosphatase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of FBP1 mRNA
CTD
PMID:16221962
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of FDFT1 mRNA
CTD
PMID:16221962
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
fumonisin B1 results in decreased expression of FDPS mRNA
CTD
PMID:16221962
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fkbp1a
FKBP prolyl isomerase 1A
increases expression
ISO
fumonisin B1 results in increased expression of FKBP1A mRNA
CTD
PMID:16221962
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
decreases expression
ISO
fumonisin B1 results in decreased expression of FMO3 mRNA
CTD
PMID:16221962
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
increases expression
ISO
fumonisin B1 results in increased expression of FMO5 mRNA
CTD
PMID:16221962
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
G
Foxa2
forkhead box A2
decreases expression
ISO
fumonisin B1 results in decreased expression of FOXA2 mRNA
CTD
PMID:16221962
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Foxp3
forkhead box P3
decreases expression
ISO
fumonisin B1 results in decreased expression of FOXP3 mRNA
CTD
PMID:27757495
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Fpgs
folylpolyglutamate synthase
decreases expression
ISO
fumonisin B1 results in decreased expression of FPGS mRNA
CTD
PMID:16221962
NCBI chr 3:15,972,800...15,993,592
Ensembl chr 3:15,972,800...15,993,563
G
Ftl1
ferritin light chain 1
increases expression
ISO
fumonisin B1 results in increased expression of FTL1 mRNA
CTD
PMID:16221962
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
decreases expression
ISO
fumonisin B1 results in decreased expression of FTO mRNA
CTD
PMID:33496827
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
fumonisin B1 results in decreased expression of G6PC1 mRNA
CTD
PMID:16221962
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
fumonisin B1 results in increased expression of GADD45A mRNA; fumonisin B1 results in increased expression of GADD45A protein
CTD
PMID:31891755
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gars1
glycyl-tRNA synthetase 1
increases expression
ISO
fumonisin B1 results in increased expression of GARS1 mRNA
CTD
PMID:16221962
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gcat
glycine C-acetyltransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of GCAT mRNA
CTD
PMID:16221962
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
G
Gclm
glutamate cysteine ligase, modifier subunit
decreases expression
ISO
fumonisin B1 results in decreased expression of GCLM mRNA
CTD
PMID:35697133
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Ghr
growth hormone receptor
decreases expression
ISO
fumonisin B1 results in decreased expression of GHR mRNA
CTD
PMID:16221962
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Glul
glutamate-ammonia ligase
decreases expression
ISO
fumonisin B1 results in decreased expression of GLUL mRNA
CTD
PMID:16221962
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Gnai2
G protein subunit alpha i2
increases expression
ISO
fumonisin B1 results in increased expression of GNAI2 mRNA
CTD
PMID:16221962
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnas
GNAS complex locus
increases expression
ISO
fumonisin B1 results in increased expression of GNAS mRNA
CTD
PMID:16221962
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnb1
G protein subunit beta 1
increases expression
ISO
fumonisin B1 results in increased expression of GNB1 mRNA
CTD
PMID:16221962
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
G
Gnmt
glycine N-methyltransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of GNMT mRNA
CTD
PMID:16221962
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
ISO
fumonisin B1 results in decreased expression of GPAM mRNA
CTD
PMID:16221962
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpt
glutamic--pyruvic transaminase
increases activity multiple interactions
ISO
fumonisin B1 results in increased activity of GPT protein [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein
CTD
PMID:17080400 PMID:30448865
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
ISO
fumonisin B1 results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grn
granulin precursor
increases expression
ISO
fumonisin B1 results in increased expression of GRN mRNA
CTD
PMID:16221962
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsdmd
gasdermin D
multiple interactions increases expression
ISO
deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of GSDMD mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of GSDMD protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of GSDMD mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of GSDMD protein] fumonisin B1 results in increased expression of GSDMD mRNA; fumonisin B1 results in increased expression of GSDMD protein
CTD
PMID:36309173
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
G
Gstm1
glutathione S-transferase mu 1
increases expression decreases expression
ISO
fumonisin B1 results in increased expression of GSTM1 mRNA fumonisin B1 results in decreased expression of GSTM1 mRNA
CTD
PMID:16221962 PMID:35697133
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
increases expression
ISO
fumonisin B1 results in increased expression of GSTM2 mRNA
CTD
PMID:16221962
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstm5
glutathione S-transferase, mu 5
increases expression
ISO
fumonisin B1 results in increased expression of GSTM3 mRNA
CTD
PMID:16221962
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gstp1
glutathione S-transferase pi 1
affects expression
ISO
fumonisin B1 affects the expression of GSTP1 mRNA
CTD
PMID:35697133
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstz1
glutathione S-transferase zeta 1
decreases expression
ISO
fumonisin B1 results in decreased expression of GSTZ1 mRNA
CTD
PMID:16221962
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
H1f2
H1.2 linker histone, cluster member
increases expression
ISO
fumonisin B1 results in increased expression of H1F2 mRNA
CTD
PMID:16221962
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
H2ax
H2A.X variant histone
decreases expression
ISO
fumonisin B1 results in decreased expression of H2AX protein
CTD
PMID:25800559
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H3f3b
H3.3 histone B
increases expression
ISO
fumonisin B1 results in increased expression of H3F3B mRNA
CTD
PMID:16221962
NCBI chr10:101,256,484...101,258,716
Ensembl chr10:101,256,480...101,258,709
G
Hagh
hydroxyacyl glutathione hydrolase
decreases expression
ISO
fumonisin B1 results in decreased expression of HAGH mRNA
CTD
PMID:16221962
NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504
G
Hal
histidine ammonia lyase
decreases expression
ISO
fumonisin B1 results in decreased expression of HAL mRNA
CTD
PMID:16221962
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
ISO
fumonisin B1 results in decreased expression of HMGCS2 mRNA
CTD
PMID:16221962
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
increases expression
ISO
fumonisin B1 results in increased expression of HMOX1 mRNA
CTD
PMID:16221962
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases expression
ISO
fumonisin B1 results in increased expression of HPRT1 mRNA
CTD
PMID:16221962
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hpx
hemopexin
increases expression
ISO
fumonisin B1 results in increased expression of HPX mRNA
CTD
PMID:16221962
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of HSD11B1 mRNA
CTD
PMID:16221962
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
decreases expression
ISO
fumonisin B1 results in decreased expression of HSD17B10 mRNA
CTD
PMID:16221962
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of HSPA5 mRNA; fumonisin B1 results in increased expression of HSPA5 protein 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein]; thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein]
CTD
PMID:31891755
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of IDI1 mRNA
CTD
PMID:16221962
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ifng
interferon gamma
increases expression affects expression multiple interactions
ISO
fumonisin B1 results in increased expression of IFNG mRNA fumonisin B1 affects the expression of IFNG mRNA 5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IFNG mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IFNG mRNA]
CTD
PMID:15590129 PMID:17080400 PMID:35697133
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
decreases expression
ISO
fumonisin B1 results in decreased expression of IGF1 mRNA
CTD
PMID:16221962
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
decreases expression
ISO
fumonisin B1 results in decreased expression of IGFALS mRNA
CTD
PMID:16221962
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
ISO
fumonisin B1 results in increased expression of IGFBP1 mRNA
CTD
PMID:16221962
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Il12a
interleukin 12A
increases expression
ISO
fumonisin B1 results in increased expression of IL12A mRNA
CTD
PMID:27757495
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il18
interleukin 18
increases secretion multiple interactions increases expression
ISO
fumonisin B1 results in increased secretion of IL18 protein deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL18 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL18 protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased secretion of IL18 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL18 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL18 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased secretion of IL18 protein] fumonisin B1 results in increased expression of IL18 mRNA; fumonisin B1 results in increased expression of IL18 protein
CTD
PMID:36309173
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases expression
ISO
fumonisin B1 results in increased expression of IL1A mRNA
CTD
PMID:17080400
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions increases secretion decreases expression increases expression
ISO
5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL1B protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased secretion of IL1B protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL1B protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased secretion of IL1B protein]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA] fumonisin B1 results in decreased expression of IL1B mRNA fumonisin B1 results in increased expression of IL1B mRNA; fumonisin B1 results in increased expression of IL1B protein
CTD
PMID:17080400 PMID:35697133 PMID:36309173
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
increases expression
ISO
fumonisin B1 results in increased expression of IL1RN mRNA
CTD
PMID:17080400
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
multiple interactions affects expression increases expression
ISO
5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IL2 mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL2 mRNA] fumonisin B1 affects the expression of IL2 mRNA
CTD
PMID:17080400 PMID:35697133
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of IL6 mRNA 5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL6 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA]
CTD
PMID:17080400 PMID:27757495 PMID:36309173
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inmt
indolethylamine N-methyltransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of INMT mRNA
CTD
PMID:16221962
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
G
Itih1
inter-alpha trypsin inhibitor, heavy chain 1
decreases expression
ISO
fumonisin B1 results in decreased expression of ITIH1 mRNA
CTD
PMID:16221962
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
decreases expression
ISO
fumonisin B1 results in decreased expression of ITIH4 mRNA
CTD
PMID:16221962
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
G
Ivd
isovaleryl-CoA dehydrogenase
decreases expression
ISO
fumonisin B1 results in decreased expression of IVD mRNA
CTD
PMID:16221962
NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
fumonisin B1 results in increased expression of JUND mRNA
CTD
PMID:16221962
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kdm5b
lysine demethylase 5B
increases expression
ISO
fumonisin B1 results in increased expression of KDM5B mRNA
CTD
PMID:24280379
NCBI chr13:46,001,589...46,073,868
Ensembl chr13:46,002,542...46,073,872
G
Kdm5c
lysine demethylase 5C
increases expression
ISO
fumonisin B1 results in increased expression of KDM5C mRNA
CTD
PMID:24280379
NCBI chr X:21,345,459...21,387,045
Ensembl chr X:21,345,481...21,381,870
G
Kdr
kinase insert domain receptor
multiple interactions
ISO
fumonisin B1 inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased phosphorylation of and results in decreased activity of KDR protein]; fumonisin B1 inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in decreased phosphorylation of and results in decreased activity of KDR protein]
CTD
PMID:15313899
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Keap1
Kelch-like ECH-associated protein 1
increases methylation decreases expression multiple interactions
ISO
fumonisin B1 results in increased methylation of KEAP1 promoter fumonisin B1 results in decreased expression of KEAP1 mRNA fumonisin B1 results in decreased expression of KEAP1 mRNA; fumonisin B1 results in decreased expression of KEAP1 protein [fumonisin B1 results in increased methylation of KEAP1 promoter] which results in decreased expression of KEAP1 mRNA
CTD
PMID:33496827 PMID:35697133
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Kitlg
KIT ligand
decreases expression
ISO
fumonisin B1 results in decreased expression of KITLG mRNA
CTD
PMID:27757495
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Klf6
KLF transcription factor 6
increases expression
ISO
fumonisin B1 results in increased expression of KLF6 mRNA
CTD
PMID:16221962
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Krt18
keratin 18
increases expression
ISO
fumonisin B1 results in increased expression of KRT18 mRNA
CTD
PMID:16221962
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krt8
keratin 8
increases expression
ISO
fumonisin B1 results in increased expression of KRT8 mRNA
CTD
PMID:16221962
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Lamp1
lysosomal-associated membrane protein 1
increases expression
ISO
fumonisin B1 results in increased expression of LAMP1 mRNA
CTD
PMID:16221962
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
G
Lasp1
LIM and SH3 protein 1
increases expression
ISO
fumonisin B1 results in increased expression of LASP1 mRNA
CTD
PMID:16221962
NCBI chr10:82,795,177...82,835,659
Ensembl chr10:82,795,137...82,943,292
G
Lcat
lecithin cholesterol acyltransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of LCAT mRNA
CTD
PMID:16221962
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lifr
LIF receptor subunit alpha
decreases expression
ISO
fumonisin B1 results in decreased expression of LIFR mRNA
CTD
PMID:16221962
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
G
Litaf
lipopolysaccharide-induced TNF factor
increases expression
ISO
fumonisin B1 results in increased expression of LITAF mRNA
CTD
PMID:16221962
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Lmna
lamin A/C
increases expression
ISO
fumonisin B1 results in increased expression of LMNA mRNA
CTD
PMID:16221962
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lpl
lipoprotein lipase
increases expression
ISO
fumonisin B1 results in increased expression of LPL mRNA
CTD
PMID:16221962
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lpo
lactoperoxidase
decreases expression
ISO
fumonisin B1 results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
G
Lsr
lipolysis stimulated lipoprotein receptor
increases expression
ISO
fumonisin B1 results in increased expression of LSR mRNA
CTD
PMID:16221962
NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
G
Ltb
lymphotoxin beta
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of LTB mRNA 5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]
CTD
PMID:15590129 PMID:17080400
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Ltbr
lymphotoxin beta receptor
decreases expression
ISO
fumonisin B1 results in decreased expression of LTBR mRNA
CTD
PMID:16221962
NCBI chr 4:158,108,884...158,115,339
Ensembl chr 4:158,108,886...158,121,539
G
Ly6e
lymphocyte antigen 6 family member E
increases expression
ISO
fumonisin B1 results in increased expression of LY6E mRNA
CTD
PMID:16221962
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
G
Lyz2
lysozyme 2
increases expression
ISO
fumonisin B1 results in increased expression of LYZ2 mRNA
CTD
PMID:16221962
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Man2b1
mannosidase, alpha, class 2B, member 1
increases expression
ISO
fumonisin B1 results in increased expression of MAN2B1 mRNA
CTD
PMID:16221962
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
G
Marco
macrophage receptor with collagenous structure
increases expression
ISO
fumonisin B1 results in increased expression of MARCO mRNA
CTD
PMID:16221962
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
G
Mbd2
methyl-CpG binding domain protein 2
multiple interactions
ISO
fumonisin B1 results in increased expression of and results in increased activity of MBD2 protein
CTD
PMID:24280379
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mbl1
mannose binding lectin 1
decreases expression
ISO
fumonisin B1 results in decreased expression of MBL1 mRNA
CTD
PMID:16221962
NCBI chr16:17,029,146...17,035,187
Ensembl chr16:17,029,118...17,035,174
G
Mdm2
MDM2 proto-oncogene
multiple interactions
ISO
fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 protein]
CTD
PMID:18206046
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
increases expression
ISO
fumonisin B1 results in increased expression of METTL14 mRNA
CTD
PMID:33496827
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
G
Mettl3
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit
increases expression
ISO
fumonisin B1 results in increased expression of METTL3 mRNA
CTD
PMID:33496827
NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041
G
Mir27b
microRNA 27b
decreases expression multiple interactions
ISO
fumonisin B1 results in decreased expression of MIR27B mRNA [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 mRNA; [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 protein; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 mRNA]; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 protein]
CTD
PMID:24614526 PMID:33496827
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of MSMO1 mRNA
CTD
PMID:16221962
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Msrb1
methionine sulfoxide reductase B1
decreases expression
ISO
fumonisin B1 results in decreased expression of MSRB1 mRNA
CTD
PMID:16221962
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
G
Mt2A
metallothionein 2A
decreases expression
ISO
fumonisin B1 results in decreased expression of MT2 mRNA
CTD
PMID:16221962
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
fumonisin B1 results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
multiple interactions increases expression
ISO
fumonisin B1 results in increased expression of and results in increased secretion of MUC5AC protein fumonisin B1 results in increased expression of MUC5AC mRNA
CTD
PMID:24496642
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
multiple interactions increases expression
ISO
fumonisin B1 results in increased expression of and results in increased secretion of MUC5B protein fumonisin B1 results in increased expression of MUC5B mRNA
CTD
PMID:24496642
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Mup4
major urinary protein 4
decreases expression
ISO
fumonisin B1 results in decreased expression of MUP4 mRNA
CTD
PMID:16221962
NCBI chr 5:74,961,143...74,964,686
Ensembl chr 5:74,842,319...75,061,474
G
Myh9
myosin, heavy chain 9
increases expression
ISO
fumonisin B1 results in increased expression of MYH9 mRNA
CTD
PMID:16221962
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
G
Myo1c
myosin 1C
increases expression
ISO
fumonisin B1 results in increased expression of MYO1C mRNA
CTD
PMID:16221962
NCBI chr10:60,498,372...60,520,752
Ensembl chr10:60,498,280...60,520,752
G
Nat8f1
N-acetyltransferase 8 (GCN5-related) family member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of NAT8F1 mRNA
CTD
PMID:16221962
NCBI chr 4:118,336,208...118,342,923
Ensembl chr 4:118,332,862...118,344,035
G
Ndufb10
NADH:ubiquinone oxidoreductase subunit B10
decreases expression
ISO
fumonisin B1 results in decreased expression of NDUFB10 mRNA
CTD
PMID:16221962
NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442
G
Ndufb11
NADH:ubiquinone oxidoreductase subunit B11
decreases expression
ISO
fumonisin B1 results in decreased expression of NDUFB11 mRNA
CTD
PMID:16221962
NCBI chr X:1,572,805...1,575,063
Ensembl chr X:1,572,785...1,575,062
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression affects expression increases methylation decreases methylation multiple interactions
ISO
fumonisin B1 results in increased expression of NFE2L2 mRNA fumonisin B1 affects the expression of NFE2L2 mRNA fumonisin B1 results in increased methylation of NFE2L2 mRNA fumonisin B1 results in decreased methylation of NFE2L2 promoter [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 mRNA; [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 protein; [fumonisin B1 results in decreased methylation of NFE2L2 promoter] which results in increased expression of NFE2L2 mRNA; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 mRNA]; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 protein] fumonisin B1 results in increased expression of NFE2L2 mRNA; fumonisin B1 results in increased expression of NFE2L2 protein
CTD
PMID:16221962 PMID:33496827 PMID:35697133
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nlrp3
NLR family, pyrin domain containing 3
increases expression multiple interactions
ISO
fumonisin B1 results in increased expression of NLRP3 mRNA; fumonisin B1 results in increased expression of NLRP3 protein deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of NLRP3 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of NLRP3 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of NLRP3 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of NLRP3 protein]
CTD
PMID:36309173
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nnmt
nicotinamide N-methyltransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of NNMT mRNA
CTD
PMID:16221962
NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
G
Nqo1
NAD(P)H quinone dehydrogenase 1
affects expression
ISO
fumonisin B1 affects the expression of NQO1 mRNA
CTD
PMID:35697133
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
affects response to substance multiple interactions
ISO
NR1H2 protein affects the susceptibility to fumonisin B1 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA
CTD
PMID:30448865
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions affects response to substance
ISO
[NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA
CTD
PMID:30448865
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
ISO
fumonisin B1 results in decreased expression of NR1I3 mRNA
CTD
PMID:16221962
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of NR3C1 mRNA
CTD
PMID:16221962
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nsdhl
NAD(P) dependent steroid dehydrogenase-like
decreases expression
ISO
fumonisin B1 results in decreased expression of NSDHL mRNA
CTD
PMID:16221962
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
G
Oat
ornithine aminotransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of OAT mRNA
CTD
PMID:16221962
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Ocln
occludin
multiple interactions decreases expression
ISO
illite inhibits the reaction [fumonisin B1 results in decreased expression of OCLN mRNA]
CTD
PMID:27153755
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Olig2
oligodendrocyte transcription factor 2
decreases expression
ISO
fumonisin B1 results in decreased expression of OLIG2 mRNA
CTD
PMID:34748853
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions decreases cleavage
EXP ISO
fumonisin B1 inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein] fumonisin B1 results in decreased cleavage of PARP1 protein
CTD
PMID:24448832 PMID:25800559
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pc
pyruvate carboxylase
decreases expression
ISO
fumonisin B1 results in decreased expression of PCX mRNA
CTD
PMID:16221962
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pcbp1
poly(rC) binding protein 1
increases expression
ISO
fumonisin B1 results in increased expression of PCBP1 mRNA
CTD
PMID:16221962
NCBI chr 4:118,972,698...118,974,705
Ensembl chr 4:118,972,661...118,976,500
G
Pdgfa
platelet derived growth factor subunit A
increases expression
ISO
fumonisin B1 results in increased expression of PDGFA mRNA
CTD
PMID:16221962
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdlim1
PDZ and LIM domain 1
increases expression
ISO
fumonisin B1 results in increased expression of PDLIM1 mRNA
CTD
PMID:16221962
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
G
Phlda1
pleckstrin homology-like domain, family A, member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of PHLDA1 mRNA
CTD
PMID:16221962
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pigr
polymeric immunoglobulin receptor
decreases expression
ISO
fumonisin B1 results in decreased expression of PIGR mRNA
CTD
PMID:16221962
NCBI chr13:42,298,905...42,326,877
Ensembl chr13:42,298,914...42,326,875
G
Pipox
pipecolic acid and sarcosine oxidase
decreases expression
ISO
fumonisin B1 results in decreased expression of PIPOX mRNA
CTD
PMID:16221962
NCBI chr10:62,769,874...62,783,484
Ensembl chr10:62,769,900...62,782,370
G
Plin2
perilipin 2
increases expression
ISO
fumonisin B1 results in increased expression of PLIN2 mRNA
CTD
PMID:16221962
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Pltp
phospholipid transfer protein
increases expression
ISO
fumonisin B1 results in increased expression of PLTP mRNA
CTD
PMID:16221962
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
G
Pon1
paraoxonase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of PON1 mRNA
CTD
PMID:16221962
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
fumonisin B1 results in decreased expression of PPARA mRNA
CTD
PMID:16221962
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppia
peptidylprolyl isomerase A
increases expression
ISO
fumonisin B1 results in increased expression of PPIA mRNA
CTD
PMID:16221962
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
multiple interactions
EXP
fumonisin B1 inhibits the reaction [Ethanol results in increased activity of PPP2CA protein]
CTD
PMID:20224005
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Prdx6
peroxiredoxin 6
decreases expression
ISO
fumonisin B1 results in decreased expression of PRDX6 mRNA
CTD
PMID:16221962
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Prlr
prolactin receptor
decreases expression
ISO
fumonisin B1 results in decreased expression of PRLR mRNA
CTD
PMID:16221962
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prodh2
proline dehydrogenase 2
decreases expression
ISO
fumonisin B1 results in decreased expression of PRODH2 mRNA
CTD
PMID:16221962
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
G
Prpf8
pre-mRNA processing factor 8
decreases expression
ISO
fumonisin B1 results in decreased expression of PRPF8 mRNA
CTD
PMID:16221962
NCBI chr10:60,331,494...60,354,606
Ensembl chr10:60,331,494...60,354,606
G
Psmd8
proteasome 26S subunit, non-ATPase 8
increases expression
ISO
fumonisin B1 results in increased expression of PSMD8 mRNA
CTD
PMID:16221962
NCBI chr 1:84,474,377...84,481,209
Ensembl chr 1:84,474,378...84,481,209
G
Ptp4a1
protein tyrosine phosphatase 4A1
increases expression
ISO
fumonisin B1 results in increased expression of PTP4A1 mRNA
CTD
PMID:16221962
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
G
Pxmp2
peroxisomal membrane protein 2
decreases expression
ISO
fumonisin B1 results in decreased expression of PXMP2 mRNA
CTD
PMID:16221962
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pycard
PYD and CARD domain containing
multiple interactions
ISO
[deoxynivalenol co-treated with fumonisin B1] results in increased expression of PYCARD mRNA; [deoxynivalenol co-treated with fumonisin B1] results in increased expression of PYCARD protein
CTD
PMID:36309173
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
G
Qdpr
quinoid dihydropteridine reductase
decreases expression
ISO
fumonisin B1 results in decreased expression of QDPR mRNA
CTD
PMID:16221962
NCBI chr14:65,670,251...65,683,853
Ensembl chr14:65,670,131...65,683,854
G
Rab7b
Rab7b, member RAS oncogene family
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA
CTD
PMID:30448865
NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases expression
ISO
fumonisin B1 results in decreased expression of RELA mRNA
CTD
PMID:35697133
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rgn
regucalcin
decreases expression
ISO
fumonisin B1 results in decreased expression of RGN mRNA
CTD
PMID:16221962
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rgs16
regulator of G-protein signaling 16
decreases expression
ISO
fumonisin B1 results in decreased expression of RGS16 mRNA
CTD
PMID:16221962
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rhoc
ras homolog family member C
increases expression
ISO
fumonisin B1 results in increased expression of RHOC mRNA
CTD
PMID:16221962
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Rhoq
ras homolog family member Q
increases expression
ISO
fumonisin B1 results in increased expression of RHOQ mRNA
CTD
PMID:16221962
NCBI chr 6:7,613,632...7,652,047
G
Rhou
ras homolog family member U
increases expression
ISO
fumonisin B1 results in increased expression of RHOU mRNA
CTD
PMID:16221962
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
G
Rnf11
ring finger protein 11
increases expression
ISO
fumonisin B1 results in increased expression of RNF11 mRNA
CTD
PMID:16221962
NCBI chr 5:124,212,433...124,243,125
Ensembl chr 5:124,212,445...124,234,750
G
Rps12
ribosomal protein S12
increases expression
ISO
fumonisin B1 results in increased expression of RPS12 mRNA
CTD
PMID:16221962
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
G
RT1-A2
RT1 class Ia, locus A2
increases expression
ISO
fumonisin B1 results in increased expression of H2-T23 mRNA
CTD
PMID:16221962
NCBI chr20:4,870,939...4,910,183
G
RT1-CE16
RT1 class I, locus CE16
increases expression
ISO
fumonisin B1 results in increased expression of H2-Q1 mRNA
CTD
PMID:16221962
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
S100a10
S100 calcium binding protein A10
increases expression
ISO
fumonisin B1 results in increased expression of S100A10 mRNA
CTD
PMID:16221962
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a11
S100 calcium binding protein A11
increases expression
ISO
fumonisin B1 results in increased expression of S100A11 mRNA
CTD
PMID:16221962
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
Sardh
sarcosine dehydrogenase
decreases expression
ISO
fumonisin B1 results in decreased expression of SARDH mRNA
CTD
PMID:16221962
NCBI chr 3:10,510,553...10,575,342
Ensembl chr 3:10,510,553...10,573,874
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
fumonisin B1 results in increased expression of SAT1 mRNA
CTD
PMID:16221962
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Serinc1
serine incorporator 1
increases expression
ISO
fumonisin B1 results in increased expression of SERINC1 mRNA
CTD
PMID:16221962
NCBI chr20:36,850,062...36,868,999
Ensembl chr20:36,850,076...36,896,691
G
Serinc3
serine incorporator 3
increases expression
ISO
fumonisin B1 results in increased expression of SERINC3 mRNA
CTD
PMID:16221962
NCBI chr 3:152,301,882...152,321,327
Ensembl chr 3:152,301,772...152,321,808
G
Serpina6
serpin family A member 6
decreases expression
ISO
fumonisin B1 results in decreased expression of SERPINA6 mRNA
CTD
PMID:16221962
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
G
Serpinb6a
serpin family B member 6A
increases expression
ISO
fumonisin B1 results in increased expression of SERPINB6 mRNA
CTD
PMID:16221962
NCBI chr17:30,871,468...30,989,703
Ensembl chr17:30,871,468...31,014,427
G
Serpine1
serpin family E member 1
multiple interactions
ISO
fumonisin B1 inhibits the reaction [Daunorubicin results in decreased expression of SERPINE1 protein]
CTD
PMID:11336794
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of SERPING1 mRNA
CTD
PMID:16221962
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sftpa1
surfactant protein A1
increases expression
ISO
fumonisin B1 results in increased expression of SFTPA1 mRNA
CTD
PMID:27376354
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpd
surfactant protein D
increases expression
ISO
fumonisin B1 results in increased expression of SFTPD mRNA
CTD
PMID:27376354
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
fumonisin B1 results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
G
Shmt1
serine hydroxymethyltransferase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of SHMT1 mRNA
CTD
PMID:16221962
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
G
Slc10a1
solute carrier family 10 member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC10A1 mRNA
CTD
PMID:16221962
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc20a1
solute carrier family 20 member 1
increases expression
ISO
fumonisin B1 results in increased expression of SLC20A1 mRNA
CTD
PMID:16221962
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a1
solute carrier family 22 member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC22A1 mRNA
CTD
PMID:16221962
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a18
solute carrier family 22, member 18
increases expression
ISO
fumonisin B1 results in increased expression of SLC22A18 mRNA
CTD
PMID:16221962
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
G
Slc27a2
solute carrier family 27 member 2
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC27A2 mRNA
CTD
PMID:16221962
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc27a5
solute carrier family 27 member 5
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC27A5 mRNA
CTD
PMID:16221962
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
G
Slc29a1
solute carrier family 29 member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC29A1 mRNA
CTD
PMID:16221962
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc31a1
solute carrier family 31 member 1
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC31A1 mRNA
CTD
PMID:16221962
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc37a4
solute carrier family 37 member 4
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC37A4 mRNA
CTD
PMID:16221962
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
G
Slc6a12
solute carrier family 6 member 12
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC6A12 mRNA
CTD
PMID:16221962
NCBI chr 4:154,585,386...154,603,750
Ensembl chr 4:154,585,500...154,603,750
G
Slc6a4
solute carrier family 6 member 4
decreases expression
ISO
fumonisin B1 results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Smpd3
sphingomyelin phosphodiesterase 3
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA
CTD
PMID:30448865
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
G
Snx3
sorting nexin 3
increases expression
ISO
fumonisin B1 results in increased expression of SNX3 mRNA
CTD
PMID:16221962
NCBI chr20:45,992,446...46,025,361
Ensembl chr20:45,992,720...46,025,379
G
Sod1
superoxide dismutase 1
increases expression
ISO
fumonisin B1 results in increased expression of SOD1 mRNA
CTD
PMID:35697133
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sphk1
sphingosine kinase 1
multiple interactions
ISO
fumonisin B1 inhibits the reaction [Particulate Matter results in increased expression of SPHK1 mRNA]; fumonisin B1 inhibits the reaction [Vehicle Emissions results in increased expression of SPHK1 mRNA]
CTD
PMID:27376354
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
fumonisin B1 results in increased expression of SPRR1A mRNA
CTD
PMID:16221962
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Sptan1
spectrin, alpha, non-erythrocytic 1
increases expression
ISO
fumonisin B1 results in increased expression of SPTAN1 mRNA
CTD
PMID:16221962
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Sptbn1
spectrin, beta, non-erythrocytic 1
increases expression
ISO
fumonisin B1 results in increased expression of SPTBN1 mRNA
CTD
PMID:16221962
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
G
Sqstm1
sequestosome 1
increases expression
ISO
fumonisin B1 results in increased expression of SQSTM1 mRNA
CTD
PMID:16221962
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
fumonisin B1 results in decreased expression of SREBF1 mRNA
CTD
PMID:16221962
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srxn1
sulfiredoxin 1
increases expression
ISO
fumonisin B1 results in increased expression of SRXN1 mRNA
CTD
PMID:16221962
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ss18l2
SS18 like 2
decreases expression
ISO
fumonisin B1 results in decreased expression of SS18L2 mRNA
CTD
PMID:16221962
NCBI chr 8:121,375,263...121,377,877
Ensembl chr 8:121,375,308...121,377,877
G
Suclg2
succinate-CoA ligase GDP-forming subunit beta
decreases expression
ISO
fumonisin B1 results in decreased expression of SUCLG2 mRNA
CTD
PMID:16221962
NCBI chr 4:128,067,031...128,337,146
Ensembl chr 4:128,067,033...128,337,170
G
Tagln2
transgelin 2
increases expression
ISO
fumonisin B1 results in increased expression of TAGLN2 mRNA
CTD
PMID:16221962
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Tdo2
tryptophan 2,3-dioxygenase
decreases expression
ISO
fumonisin B1 results in decreased expression of TDO2 mRNA
CTD
PMID:16221962
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
G
Tff2
trefoil factor 2
decreases expression
ISO
fumonisin B1 results in decreased expression of TFF2 mRNA
CTD
PMID:16221962
NCBI chr20:9,215,750...9,219,619
Ensembl chr20:9,215,761...9,219,619
G
Tfr2
transferrin receptor 2
decreases expression
ISO
fumonisin B1 results in decreased expression of TFR2 mRNA
CTD
PMID:16221962
NCBI chr12:19,107,673...19,124,622
Ensembl chr12:19,107,673...19,124,591
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
fumonisin B1 results in increased expression of TGFB1 mRNA
CTD
PMID:15590129
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Thrsp
thyroid hormone responsive
decreases expression
ISO
fumonisin B1 results in decreased expression of THRSP mRNA
CTD
PMID:16221962
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Tm7sf2
transmembrane 7 superfamily member 2
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA
CTD
PMID:30448865
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
G
Tmem176b
transmembrane protein 176B
increases expression
ISO
fumonisin B1 results in increased expression of TMEM176B mRNA
CTD
PMID:16221962
NCBI chr 4:77,766,928...77,774,740
Ensembl chr 4:77,766,928...77,774,384
G
Tnf
tumor necrosis factor
increases expression decreases expression
ISO
fumonisin B1 results in increased expression of TNF mRNA fumonisin B1 results in decreased expression of TNF mRNA; fumonisin B1 results in decreased expression of TNF protein
CTD
PMID:15590129 PMID:17080400 PMID:35697133
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
ISO
fumonisin B1 results in increased expression of TNFRSF1A mRNA
CTD
PMID:15590129
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfsf10
TNF superfamily member 10
increases expression
ISO
fumonisin B1 results in increased expression of TNFSF10 mRNA
CTD
PMID:15590129
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
multiple interactions increases expression decreases expression
ISO EXP
[fumonisin B1 results in decreased chemical synthesis of Ceramides] which affects the splicing of and results in decreased expression of TP53 mRNA; [fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased phosphorylation of TP53 protein modified form Acetylcysteine inhibits the reaction [Aflatoxin B1 promotes the reaction [fumonisin B1 results in increased expression of TP53 protein]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Aflatoxin B1 results in increased expression of TP53 protein]]; Aflatoxin B1 promotes the reaction [fumonisin B1 results in increased expression of TP53 protein]; fumonisin B1 promotes the reaction [Aflatoxin B1 results in increased expression of TP53 protein] fumonisin B1 results in decreased expression of TP53 mRNA
CTD
PMID:25195822 PMID:27757495 PMID:28181396
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpm1
tropomyosin 1
increases expression
ISO
fumonisin B1 results in increased expression of TPM1 mRNA
CTD
PMID:16221962
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
G
Tpp1
tripeptidyl peptidase 1
increases expression
ISO
fumonisin B1 results in increased expression of TPP1 mRNA
CTD
PMID:16221962
NCBI chr 1:160,097,984...160,104,108
Ensembl chr 1:160,096,833...160,104,129
G
Tspo
translocator protein
increases expression
ISO
fumonisin B1 results in increased expression of TSPO mRNA
CTD
PMID:16221962
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
G
Tst
thiosulfate sulfurtransferase
decreases expression
ISO
fumonisin B1 results in decreased expression of TST mRNA
CTD
PMID:16221962
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
G
Ttr
transthyretin
decreases expression
ISO
fumonisin B1 results in decreased expression of TTR mRNA
CTD
PMID:16221962
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Tubb2a
tubulin, beta 2A class IIa
increases expression
ISO
fumonisin B1 results in increased expression of TUBB2A mRNA
CTD
PMID:16221962
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Tubb3
tubulin, beta 3 class III
increases expression
ISO
fumonisin B1 results in increased expression of TUBB3 mRNA
CTD
PMID:16221962
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb5
tubulin, beta 5 class I
increases expression
ISO
fumonisin B1 results in increased expression of TUBB5 mRNA
CTD
PMID:16221962
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Txn1
thioredoxin 1
increases expression
ISO
fumonisin B1 results in increased expression of TXN1 mRNA
CTD
PMID:16221962
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
decreases expression
ISO
fumonisin B1 results in decreased expression of TXN2 mRNA
CTD
PMID:16221962
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Tymp
thymidine phosphorylase
decreases expression
ISO
fumonisin B1 results in decreased expression of TYMP mRNA
CTD
PMID:16221962
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Ube2n
ubiquitin-conjugating enzyme E2N
increases expression
ISO
fumonisin B1 results in increased expression of UBE2N mRNA
CTD
PMID:16221962
NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355
G
Ugcg
UDP-glucose ceramide glucosyltransferase
multiple interactions
ISO
fumonisin B1 inhibits the reaction [Doxorubicin results in increased expression of UGCG mRNA]
CTD
PMID:18245173
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
ISO
fumonisin B1 results in increased expression of UGDH mRNA
CTD
PMID:16221962
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
multiple interactions
ISO
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA
CTD
PMID:30448865
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ulk1
unc-51 like autophagy activating kinase 1
decreases expression
ISO
fumonisin B1 results in decreased expression of ULK1 mRNA
CTD
PMID:16221962
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Usp15
ubiquitin specific peptidase 15
decreases expression
ISO
fumonisin B1 results in decreased expression of USP15 mRNA
CTD
PMID:16221962
NCBI chr 7:58,756,714...58,848,778
Ensembl chr 7:58,756,872...58,848,721
G
Usp18
ubiquitin specific peptidase 18
increases expression
ISO
fumonisin B1 results in increased expression of USP18 mRNA
CTD
PMID:16221962
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Vapa
VAMP associated protein A
increases expression
ISO
fumonisin B1 results in increased expression of VAPA mRNA
CTD
PMID:16221962
NCBI chr 9:105,177,904...105,208,400
Ensembl chr 9:105,177,907...105,207,847
G
Vcl
vinculin
increases expression
ISO
fumonisin B1 results in increased expression of VCL mRNA
CTD
PMID:16221962
NCBI chr15:3,265,776...3,355,586
Ensembl chr15:3,265,815...3,355,606
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
fumonisin B1 inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased expression of and results in decreased secretion of VEGFA protein]; fumonisin B1 inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in decreased expression of and results in decreased secretion of VEGFA protein]
CTD
PMID:15313899
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vps35
VPS35 retromer complex component
increases expression
ISO
fumonisin B1 results in increased expression of VPS35 mRNA
CTD
PMID:16221962
NCBI chr19:21,765,771...21,801,620
Ensembl chr19:21,765,749...21,801,618
G
Ythdc2
YTH N6-methyladenosine RNA binding protein C2
increases expression
ISO
fumonisin B1 results in increased expression of YTHDC2 mRNA
CTD
PMID:33496827
NCBI chr18:37,266,559...37,331,681
Ensembl chr18:37,265,836...37,331,023
G
Ythdf1
YTH N6-methyladenosine RNA binding protein F1
increases expression
ISO
fumonisin B1 results in increased expression of YTHDF1 mRNA
CTD
PMID:33496827
NCBI chr 3:168,024,660...168,040,172
Ensembl chr 3:168,024,663...168,040,172
G
Ythdf2
YTH N6-methyladenosine RNA binding protein F2
increases expression
ISO
fumonisin B1 results in increased expression of YTHDF2 mRNA
CTD
PMID:33496827
NCBI chr 5:144,381,426...144,407,126
Ensembl chr 5:144,381,431...144,408,144
G
Ythdf3
YTH N6-methyladenosine RNA binding protein F3
increases expression
ISO
fumonisin B1 results in increased expression of YTHDF3 mRNA
CTD
PMID:33496827
NCBI chr 2:98,350,304...98,384,608
Ensembl chr 2:98,350,588...98,384,606
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
increases expression
ISO
fumonisin B1 results in increased expression of YWHAG mRNA
CTD
PMID:16221962
NCBI chr12:20,744,500...20,772,828
Ensembl chr12:20,744,535...20,772,827
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
increases expression
ISO
fumonisin B1 results in increased expression of YWHAH mRNA
CTD
PMID:16221962
NCBI chr14:77,696,332...77,705,715
Ensembl chr14:77,696,333...77,705,741
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
increases expression
ISO
fumonisin B1 results in increased expression of YWHAZ mRNA
CTD
PMID:16221962
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
decreases expression
ISO
fumonisin B1 results in decreased expression of ZAP70 mRNA
CTD
PMID:16221962
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases activity
ISO
fumonisin B2 results in decreased activity of PPARG protein
CTD
PMID:27481073
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
kansuinin B inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]
CTD
PMID:35101544
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Acsl4
acyl-CoA synthetase long-chain family member 4
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of ACSL4 protein]]
CTD
PMID:35093381
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Amotl1
angiomotin-like 1
multiple interactions decreases response to substance
ISO
Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein] Verteporfin results in decreased susceptibility to AMOTL1 protein
CTD
PMID:34480788
NCBI chr 8:11,348,651...11,467,564
Ensembl chr 8:11,353,674...11,467,573
G
Ankrd1
ankyrin repeat domain 1
multiple interactions decreases expression
ISO
verteporfin inhibits the reaction [YAP1 protein results in increased expression of ANKRD1 mRNA] Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of ANKRD1 mRNA] verteporfin results in decreased expression of ANKRD1 mRNA
CTD
PMID:29725256 PMID:29893953
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]
CTD
PMID:35093381
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]
CTD
PMID:35093381
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions
ISO
Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of BIRC5 mRNA]
CTD
PMID:29893953
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Casp9
caspase 9
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of and results in increased cleavage of CASP9 protein]]
CTD
PMID:35093381
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]
CTD
PMID:31812773
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL5 protein]
CTD
PMID:31812773
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
multiple interactions decreases expression
ISO
Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN1 mRNA] Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CCN1 mRNA] Verteporfin results in decreased expression of CCN1 mRNA
CTD
PMID:29725256 PMID:29893953
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
decreases expression multiple interactions
ISO
Verteporfin results in decreased expression of CCN2 mRNA Verteporfin inhibits the reaction [[XMU-MP-1 co-treated with Cadmium Chloride] results in increased expression of CCN2 mRNA] Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN2 mRNA]
CTD
PMID:29725256 PMID:35027733
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
multiple interactions
ISO
Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CCNA2 mRNA]
CTD
PMID:29893953
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
multiple interactions
ISO
Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CCNB1 mRNA]
CTD
PMID:29893953
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Cma1
chymase 1
multiple interactions
ISO
Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CMA1 protein]
CTD
PMID:31812773
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CSF3 protein]
CTD
PMID:31812773
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP2B10 mRNA]
CTD
PMID:29893953
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c24
cytochrome P450, family 2, subfamily c, polypeptide 24
multiple interactions
ISO
Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP2C55 mRNA]
CTD
PMID:29893953
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
G
Fundc1
FUN14 domain containing 1
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of FUNDC1 protein]]
CTD
PMID:35093381
NCBI chr X:5,083,635...5,100,293
Ensembl chr X:5,083,617...5,100,284
G
Gpx4
glutathione peroxidase 4
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of GPX4 protein]]
CTD
PMID:35093381
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Hmox1
heme oxygenase 1
increases expression
ISO
verteporfin results in increased expression of HMOX1 protein
CTD
PMID:16462769
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il6
interleukin 6
multiple interactions
ISO
[EVP 4593 co-treated with Verteporfin] inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA] Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]
CTD
PMID:31812773
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jak1
Janus kinase 1
multiple interactions decreases expression
ISO
[Verteporfin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of JAK1 protein Verteporfin results in decreased expression of JAK1 protein
CTD
PMID:31812773
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
decreases expression multiple interactions
ISO
Verteporfin results in decreased expression of JAK2 protein [Verteporfin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of JAK2 protein
CTD
PMID:31812773
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Mcm2
minichromosome maintenance complex component 2
multiple interactions
ISO
Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of MCM2 mRNA]
CTD
PMID:29893953
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
Verteporfin inhibits the reaction [perfluorooctanoic acid results in increased expression of MKI67 protein]
CTD
PMID:36152675
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mt2A
metallothionein 2A
multiple interactions
ISO
[Verteporfin co-treated with XMU-MP-1] promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA]
CTD
PMID:35027733
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Nppb
natriuretic peptide B
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of NPPB protein]]
CTD
PMID:35093381
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Opa1
OPA1, mitochondrial dynamin like GTPase
multiple interactions
EXP
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein]]
CTD
PMID:35093381
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Verteporfin results in increased cleavage of PARP1 protein
CTD
PMID:31494105
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Rasal2
RAS protein activator like 2
multiple interactions
ISO
Verteporfin inhibits the reaction [RASAL2 protein results in increased activity of YAP1 protein]
CTD
PMID:34826200
NCBI chr13:69,279,882...69,569,161
Ensembl chr13:69,258,622...69,569,940
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Verteporfin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of RELA protein; Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of and results in increased phosphorylation of RELA protein]
CTD
PMID:31812773
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Stat1
signal transducer and activator of transcription 1
decreases expression multiple interactions
ISO
Verteporfin results in decreased expression of STAT1 protein Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased phosphorylation of STAT1 protein]
CTD
PMID:31812773
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases expression
ISO
Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased phosphorylation of STAT3 protein] Verteporfin results in decreased expression of STAT3 protein
CTD
PMID:31812773
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tead1
TEA domain transcription factor 1
multiple interactions
ISO
Verteporfin inhibits the reaction [YAP1 protein binds to TEAD1 protein]
CTD
PMID:29893953
NCBI chr 1:166,791,900...167,010,591
Ensembl chr 1:166,792,628...167,003,369
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein] [EVP 4593 co-treated with Verteporfin] inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]
CTD
PMID:31812773
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Yap1
Yes1 associated transcriptional regulator
multiple interactions decreases expression decreases activity
ISO EXP
Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein]; Verteporfin inhibits the reaction [RASAL2 protein results in increased activity of YAP1 protein]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of ANKRD1 mRNA]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN1 mRNA]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN2 mRNA] Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]] Verteporfin results in decreased expression of YAP1 protein Verteporfin results in decreased activity of YAP1 protein Verteporfin inhibits the reaction [YAP1 protein binds to TEAD1 protein]
CTD
PMID:29725256 PMID:29893953 PMID:31494105 PMID:34351699 PMID:34480788 PMID:34826200 PMID:35093381 More...
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19841
chemical entity
19839
group
19798
inorganic group
19393
oxo group
18898
organic oxo compound
18898
carbonyl compound
18898
carboxylic acid
18638
tetracarboxylic acid
540
( -)-1-hydroxybybetaochlamic acid
0
(-)-1-Hydroxybybetaochlamic acid
0
(2R,2(1)S)-2(1),2(2)-dicarboxy-8-ethenyl-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13,17-dipropanoic acid +
36
(2R,3R)-14-diacetyl-1,2,3,4-butanetetraol-2,3-diorsellinate
0
(2S,2(1)R)-2(1),2(2)-dicarboxy-8-ethenyl-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13,17-dipropanoic acid +
36
(S)-1-(4-bromoacetamidobenzyl)EDTA
0
(S)-2-(4-(2-bromoacetamido)benzyl)-DOTA
0
(S)-2-(4-nitrobenzyl)-DOTA
0
(S)-2-\{4-[2-(2-hydroxyethylthio)acetamido]benzyl\}-DOTA
0
1,6-Di-O-acetyl-2,5-bis-O-(2-isocyano-3-methyl-2-butenoyl)-D-mannitol
0
1-(4-(5-Maleimidopentyl)aminobenzyl)ethylenediaminetetraacetic acid
0
1-alpha-Acevaltrate
0
2,2-dimethylpropanoic acid [[1-[bis[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]-1-(4-hydroxyphenoxy)ethyl]-[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]oxymethyl ester
0
2-(acetyloxy)-3-amino-1-[1,2-di(acetyloxy)ethyl]-3-oxopropyl acetate
0
2-Feruloylhydroxycitric acid
0
2-Methylidene-3-(6-oxalooxyhexyl)butanedioic acid
0
2-O-Caffeoylhydroxycitric acid
0
2-[4,7,10-Tris(carboxymethyl)-6-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]butyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
0
3'-(2'',3''-Digalloyl-4'',6''-hexahydroxydiphenoylglucosyl)-phloroacetophenone
0
3-Hydroxy-5-(3-hydroxy-5-(3-hydroxy-5-(3,5-dihydroxydecanoyloxy)decanoyloxy)decanoyloxy)decanoic acid
0
3-[(2R)-2-[2,5-dioxo-4-(2-oxohexyl)uran-3-yl]heptyl]-4-(hydroxymethyl)uran-2,5-dione
0
3-nitropropanoic acid [(2R,3R,4S,5R,6R)-6-hydroxy-3,4,5-tris(3-nitro-1-oxopropoxy)-2-oxanyl]methyl ester
0
4',8''-diacetoxy butyrolactone VI
0
4-[(2R)-2-[2,5-dioxo-4-(2-oxohexyl)uran-3-yl]heptyl]-2-hydroxy-5-oxo-2H-uran-3-carboxylic acid
0
4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA
0
5-hydroxy-deoxyscytalidin
0
6-Hydroxysandoricin
0
6A-Methylpenicillactone A
0
6a, 3'-p-Dihydroxypaclitaxel
0
7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylic acid tetramethyl ester
0
7-acetoxydehydroaustinol
0
7-hydroxydehydroaustin
0
Acetyl tributyl citrate
39
Ascotrichester B
0
Ascotrichester C
0
Asperbutenolide A
0
Aspergide
0
Austin
0
BAPTA +
47
Botryoanhydride
0
Bybetaochlamic acid
0
CP-225,917
0
CP-263,114
0
Castaneiolide
0
Ceramidastin
0
Chenopodolin B
0
Cochliodone C
0
Cochliodone F
0
Cochphthester B
0
Coloradocin
0
Cryptoporic acid P
0
Cryptoporic acid Q
0
Cyclohexane-1,2,4,5-tetracarboxylic acid
0
Cyclohexane-1,2-diaminetetraacetic acid
0
Decipinin A
0
Dehydroaustin
0
Deoxyscytalidin
0
Desacetoxy-zaragozic acid C
0
Fusariumester B
0
G b SA acetate
0
G beta-S5
0
Gemmacolide L, (rel)-
0
Ghanamycin A
0
Ghanamycin B
0
Glaucanic acid
0
Glutamic acid glutamate
0
Gomphrenin-V
0
Grahamine A, (rel)-
0
Grahamine B, (rel)-
0
Grahamine C, (rel)-
0
Grahamine D, (rel)-
0
H b S
0
H4atta
0
Halymecin C
0
Halymecin D
0
Hansforester A
0
Hansforester B
0
Hansforester D
0
Hansforester E
0
Hansforester F
0
Hansforester H
0
Hansforester I
0
Hualyzin
0
Isoaustin
0
LSM-2963
0
Liposidomycin B
0
Lustromycin
0
Lyngbyabellin P
0
Mangrovlide A
0
Menadiol disuccinate
0
Miraxanthin-II
0
Musca-aurin-II
0
Muscapurpurin
0
Noduliprevenone
0
Norbadion A
0
O-demethylpaulomycin A
0
O-demethylpaulomycin B
0
Paecilin E
0
Paulomycin A
0
Paulomycin A2
0
Paulomycin B
0
Paulomycin C
0
Paulomycin D
0
Penicillactone A
0
Phellodonin
0
Plantaricin BN
0
Quaesitic acid
0
Rhizoferrin
0
Rubratoxin acid A
0
Rubratoxin acid B
0
Rubratoxin acid C
0
Rubratoxin acid E
0
S b CA acetate
0
S b G-5,5-G b S A CH2
0
S b SA acetate
0
Sandoricin
0
Sarcodonin
0
Scytalidin
0
Skeletocutin E
0
Skeletocutin J
0
Skeletocutin K
0
Skeletocutin L
0
Skeletocutin M
0
Skeletocutin N
0
Skeletocutin O
0
Spiculisporic acid E
0
Sporochartine F
0
Squalestatin H1
0
Squalestatin S2
0
Squalestatin S3
0
Squalestatin S4
0
Squalestatin S5
0
Squalestatin S8
0
Squalestatin U2
0
Squalestatin V
0
Squalestatin V2
0
Squalestatin W2
0
Squalestatin-H1
0
Talapolyester A
0
Talapolyester B
0
Talapolyester C
0
Talapolyester D
0
Talarodride
0
Talaromytin
0
Tandyukisin F
0
Tricholomenyn C
0
Tricholomenyn D
0
Tricholomenyn E
0
Tyromycin A
0
U-77,802
0
U-77,803
0
Verruculosin B
0
Viburspiran
0
Vulgaxanthin-II
0
Xylaromanone A
0
Xylaromanone B
0
Zaragozic acid E
0
[(2R,3R,4S,5R,6R)-3,4,5-Triacetyloxy-6-[4-(4-chlorophenyl)-3-cyano-2-oxo-6-pyridin-2-ylpyridin-1-yl]oxan-2-yl]methyl acetate
0
[(2R,3R,4S,5S)-3,4-bis(3-methylbutanoyloxy)-5-(3-methylbutanoyloxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl 3-methylbutanoate
0
[6-Acetyloxy-7-hydroxy-1-(3-methylbutanoyloxy)-7-(3-methylbutanoyloxymethyl)-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate
0
achromobactin free acid
0
alpha-beta-Xylose Acetate
0
beta-citrylglutamic acid
0
chicoric acid
7
citrafungin A
0
citrafungin B
0
coproporphyrinogen +
1
dipyrromethane cofactor
0
ethylene glycol bis(2-aminoethyl)tetraacetic acid
74
ethylenediaminetetraacetic acid
52
ferroheme d1
0
fumonisin +
371
kansuinin B
1
lignin cw compound-100
0
lignin cw compound-1005
0
lignin cw compound-1007
0
lignin cw compound-1019
0
lignin cw compound-1021
0
lignin cw compound-1023
0
lignin cw compound-1025
0
lignin cw compound-137
0
lignin cw compound-140
0
lignin cw compound-2011
0
lignin cw compound-2016
0
lignin cw compound-2022
0
lignin cw compound-2073
0
lignin cw compound-2074
0
lignin cw compound-2075
0
lignin cw compound-2077
0
lignin cw compound-213
0
lignin cw compound-240
0
lignin cw compound-260
0
lignin cw compound-272
0
lignin cw compound-278
0
lignin cw compound-282
0
lignin cw compound-97
0
lignin cw compound-98
0
nicofuranose
0
pentane-1,2,3,5-tetracarboxylic acid
0
pyromellitic acid
0
sodium-binding benzofuran isophthalate
0
succinyl lactate
0
Path 2
CHEBI ontology
19841
subatomic particle
19839
composite particle
19839
hadron
19839
baryon
19839
nucleon
19839
atomic nucleus
19839
atom
19839
main group element atom
19789
p-block element atom
19789
carbon group element atom
19737
carbon atom
19733
organic molecular entity
19733
heteroorganic entity
19492
organochalcogen compound
19255
organooxygen compound
19172
carbon oxoacid
18641
carboxylic acid
18638
tetracarboxylic acid
540
( -)-1-hydroxybybetaochlamic acid
0
(-)-1-Hydroxybybetaochlamic acid
0
(2R,2(1)S)-2(1),2(2)-dicarboxy-8-ethenyl-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13,17-dipropanoic acid +
36
(2R,3R)-14-diacetyl-1,2,3,4-butanetetraol-2,3-diorsellinate
0
(2S,2(1)R)-2(1),2(2)-dicarboxy-8-ethenyl-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13,17-dipropanoic acid +
36
(S)-1-(4-bromoacetamidobenzyl)EDTA
0
(S)-2-(4-(2-bromoacetamido)benzyl)-DOTA
0
(S)-2-(4-nitrobenzyl)-DOTA
0
(S)-2-\{4-[2-(2-hydroxyethylthio)acetamido]benzyl\}-DOTA
0
1,6-Di-O-acetyl-2,5-bis-O-(2-isocyano-3-methyl-2-butenoyl)-D-mannitol
0
1-(4-(5-Maleimidopentyl)aminobenzyl)ethylenediaminetetraacetic acid
0
1-alpha-Acevaltrate
0
2,2-dimethylpropanoic acid [[1-[bis[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]-1-(4-hydroxyphenoxy)ethyl]-[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]oxymethyl ester
0
2-(acetyloxy)-3-amino-1-[1,2-di(acetyloxy)ethyl]-3-oxopropyl acetate
0
2-Feruloylhydroxycitric acid
0
2-Methylidene-3-(6-oxalooxyhexyl)butanedioic acid
0
2-O-Caffeoylhydroxycitric acid
0
2-[4,7,10-Tris(carboxymethyl)-6-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]butyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
0
3'-(2'',3''-Digalloyl-4'',6''-hexahydroxydiphenoylglucosyl)-phloroacetophenone
0
3-Hydroxy-5-(3-hydroxy-5-(3-hydroxy-5-(3,5-dihydroxydecanoyloxy)decanoyloxy)decanoyloxy)decanoic acid
0
3-[(2R)-2-[2,5-dioxo-4-(2-oxohexyl)uran-3-yl]heptyl]-4-(hydroxymethyl)uran-2,5-dione
0
3-nitropropanoic acid [(2R,3R,4S,5R,6R)-6-hydroxy-3,4,5-tris(3-nitro-1-oxopropoxy)-2-oxanyl]methyl ester
0
4',8''-diacetoxy butyrolactone VI
0
4-[(2R)-2-[2,5-dioxo-4-(2-oxohexyl)uran-3-yl]heptyl]-2-hydroxy-5-oxo-2H-uran-3-carboxylic acid
0
4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA
0
5-hydroxy-deoxyscytalidin
0
6-Hydroxysandoricin
0
6A-Methylpenicillactone A
0
6a, 3'-p-Dihydroxypaclitaxel
0
7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylic acid tetramethyl ester
0
7-acetoxydehydroaustinol
0
7-hydroxydehydroaustin
0
Acetyl tributyl citrate
39
Ascotrichester B
0
Ascotrichester C
0
Asperbutenolide A
0
Aspergide
0
Austin
0
BAPTA +
47
Botryoanhydride
0
Bybetaochlamic acid
0
CP-225,917
0
CP-263,114
0
Castaneiolide
0
Ceramidastin
0
Chenopodolin B
0
Cochliodone C
0
Cochliodone F
0
Cochphthester B
0
Coloradocin
0
Cryptoporic acid P
0
Cryptoporic acid Q
0
Cyclohexane-1,2,4,5-tetracarboxylic acid
0
Cyclohexane-1,2-diaminetetraacetic acid
0
Decipinin A
0
Dehydroaustin
0
Deoxyscytalidin
0
Desacetoxy-zaragozic acid C
0
Fusariumester B
0
G b SA acetate
0
G beta-S5
0
Gemmacolide L, (rel)-
0
Ghanamycin A
0
Ghanamycin B
0
Glaucanic acid
0
Glutamic acid glutamate
0
Gomphrenin-V
0
Grahamine A, (rel)-
0
Grahamine B, (rel)-
0
Grahamine C, (rel)-
0
Grahamine D, (rel)-
0
H b S
0
H4atta
0
Halymecin C
0
Halymecin D
0
Hansforester A
0
Hansforester B
0
Hansforester D
0
Hansforester E
0
Hansforester F
0
Hansforester H
0
Hansforester I
0
Hualyzin
0
Isoaustin
0
LSM-2963
0
Liposidomycin B
0
Lustromycin
0
Lyngbyabellin P
0
Mangrovlide A
0
Menadiol disuccinate
0
Miraxanthin-II
0
Musca-aurin-II
0
Muscapurpurin
0
Noduliprevenone
0
Norbadion A
0
O-demethylpaulomycin A
0
O-demethylpaulomycin B
0
Paecilin E
0
Paulomycin A
0
Paulomycin A2
0
Paulomycin B
0
Paulomycin C
0
Paulomycin D
0
Penicillactone A
0
Phellodonin
0
Plantaricin BN
0
Quaesitic acid
0
Rhizoferrin
0
Rubratoxin acid A
0
Rubratoxin acid B
0
Rubratoxin acid C
0
Rubratoxin acid E
0
S b CA acetate
0
S b G-5,5-G b S A CH2
0
S b SA acetate
0
Sandoricin
0
Sarcodonin
0
Scytalidin
0
Skeletocutin E
0
Skeletocutin J
0
Skeletocutin K
0
Skeletocutin L
0
Skeletocutin M
0
Skeletocutin N
0
Skeletocutin O
0
Spiculisporic acid E
0
Sporochartine F
0
Squalestatin H1
0
Squalestatin S2
0
Squalestatin S3
0
Squalestatin S4
0
Squalestatin S5
0
Squalestatin S8
0
Squalestatin U2
0
Squalestatin V
0
Squalestatin V2
0
Squalestatin W2
0
Squalestatin-H1
0
Talapolyester A
0
Talapolyester B
0
Talapolyester C
0
Talapolyester D
0
Talarodride
0
Talaromytin
0
Tandyukisin F
0
Tricholomenyn C
0
Tricholomenyn D
0
Tricholomenyn E
0
Tyromycin A
0
U-77,802
0
U-77,803
0
Verruculosin B
0
Viburspiran
0
Vulgaxanthin-II
0
Xylaromanone A
0
Xylaromanone B
0
Zaragozic acid E
0
[(2R,3R,4S,5R,6R)-3,4,5-Triacetyloxy-6-[4-(4-chlorophenyl)-3-cyano-2-oxo-6-pyridin-2-ylpyridin-1-yl]oxan-2-yl]methyl acetate
0
[(2R,3R,4S,5S)-3,4-bis(3-methylbutanoyloxy)-5-(3-methylbutanoyloxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl 3-methylbutanoate
0
[6-Acetyloxy-7-hydroxy-1-(3-methylbutanoyloxy)-7-(3-methylbutanoyloxymethyl)-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate
0
achromobactin free acid
0
alpha-beta-Xylose Acetate
0
beta-citrylglutamic acid
0
chicoric acid
7
citrafungin A
0
citrafungin B
0
coproporphyrinogen +
1
dipyrromethane cofactor
0
ethylene glycol bis(2-aminoethyl)tetraacetic acid
74
ethylenediaminetetraacetic acid
52
ferroheme d1
0
fumonisin +
371
kansuinin B
1
lignin cw compound-100
0
lignin cw compound-1005
0
lignin cw compound-1007
0
lignin cw compound-1019
0
lignin cw compound-1021
0
lignin cw compound-1023
0
lignin cw compound-1025
0
lignin cw compound-137
0
lignin cw compound-140
0
lignin cw compound-2011
0
lignin cw compound-2016
0
lignin cw compound-2022
0
lignin cw compound-2073
0
lignin cw compound-2074
0
lignin cw compound-2075
0
lignin cw compound-2077
0
lignin cw compound-213
0
lignin cw compound-240
0
lignin cw compound-260
0
lignin cw compound-272
0
lignin cw compound-278
0
lignin cw compound-282
0
lignin cw compound-97
0
lignin cw compound-98
0
nicofuranose
0
pentane-1,2,3,5-tetracarboxylic acid
0
pyromellitic acid
0
sodium-binding benzofuran isophthalate
0
succinyl lactate
0